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I. SECTIONS OF H.R. 6621 UNRELATED TO AIA 
 
 
A.  H.R. 6621 section 1(h):  
 
PATENT TERM ADJUSTMENTS.—Section 154(b) of title 35, United States Code, is 
amended—  
(1) in paragraph (1)— 
(A) in subparagraph (A)(i)(II), by striking ‘‘on which an international 
application fulfilled the requirements of section 371 of this title’’ and inserting 
‘‘of commencement of the national stage under section 371 in an international 
application’’; and 
(B) in subparagraph (B), in the matter preceding clause (i), by striking 
‘‘the application in the United States’’ and inserting ‘‘the application under 
section 111(a) in the United States or, in the case of an international application, 
the date of commencement of the national stage under section 371 in the 
international application’’; 
 
(2) in paragraph (3)(B)(i), by striking ‘‘with the written notice of allowance of the 
application under section 151’’ and inserting ‘‘no later than the date of issuance of the 
patent’’; and  
 
(3) in paragraph (4)(A)— 
(A) by striking ‘‘a determination made by the Director under paragraph 
(3) shall have remedy’’ and inserting ‘‘the Director’s decision on the applicant’s 
request for reconsideration under paragraph (3)(B)(ii) shall have exclusive 
remedy’’; and  
(B) by striking ‘‘the grant of the patent’’ and inserting ‘‘the date of the 
Director’s decision on the applicant’s request for reconsideration’’ 
 
Resulting Redline of Section 154(b): 
(b) Adjustment of patent term.-- 
(1) Patent term guarantees.--  
(A) Guarantee of prompt Patent and Trademark Office responses.--Subject 
to the limitations under paragraph (2), if the issue of an original patent is delayed 
due to the failure of the Patent and Trademark Office to--  
(i) provide at least one of the notifications under section 132 or a 
notice of allowance under section 151 not later than 14 months after--  
(I) the date on which an application was filed under section 
111(a); or  
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(II) the date on which an international application 
fulfilled the requirements of section 371of commencement of 
the national stage under section 371 in an international 
application;  
(ii) respond to a reply under section 132, or to an appeal taken 
under section 134, within 4 months after the date on which the reply was 
filed or the appeal was taken;  
(iii) act on an application within 4 months after the date of a 
decision by the Board of Patent Appeals and Interferences under section 
134 or 135 or a decision by a Federal court under section 141, 145, or 146 
in a case in which allowable claims remain in the application; or  
(iv) issue a patent within 4 months after the date on which the issue 
fee was paid under section 151 and all outstanding requirements were 
satisfied,  
the term of the patent shall be extended 1 day for each day 
after the end of the period specified in clause (i), (ii), (iii), or (iv), 
as the case may be, until the action described in such clause is 
taken.  
(B) Guarantee of no more than 3-year application pendency.--Subject to 
the limitations under paragraph (2), if the issue of an original patent is delayed 
due to the failure of the United States Patent and Trademark Office to issue a 
patent within 3 years after the actual filing date of the application in the United 
Statesthe application under section 111(a) in the United States or, in the case 
of an international application, the date of commencement of the national 
stage under section 371 in the international application, not including--  
(i) any time consumed by continued examination of the application 
requested by the applicant under section 132(b);  
(ii) any time consumed by a proceeding under section 135(a), any 
time consumed by the imposition of an order under section 181, or any 
time consumed by appellate review by the Board of Patent Appeals and 
Interferences or by a Federal court; or  
(iii) any delay in the processing of the application by the United 
States Patent and Trademark Office requested by the applicant except as 
permitted by paragraph (3)(C),  
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the term of the patent shall be extended 1 day for each day 
after the end of that 3-year period until the patent is issued.  
(C) Guarantee or adjustments for delays due to interferences[AIA § 
3(j)(2)(B) changes this to “derivation proceedings” effective March 16, 2013], 
secrecy orders, and appeals.--Subject to the limitations under paragraph (2), if the 
issue of an original patent is delayed due to--  
(i) a proceeding under section 135(a);  
(ii) the imposition of an order under section 181; or  
(iii) appellate review by the Board of Patent Appeals and 
Interferences or by a Federal court in a case in which the patent was issued 
under a decision in the review reversing an adverse determination of 
patentability,  
the term of the patent shall be extended 1 day for each day 
of the pendency of the proceeding, order, or review, as the case 
may be.  
(2) Limitations.--  
(A) In general.--To the extent that periods of delay attributable to grounds 
specified in paragraph (1) overlap, the period of any adjustment granted under this 
subsection shall not exceed the actual number of days the issuance of the patent 
was delayed.  
(B) Disclaimed term.--No patent the term of which has been disclaimed 
beyond a specified date may be adjusted under this section beyond the expiration 
date specified in the disclaimer.  
(C) Reduction of period of adjustment.--  
(i) The period of adjustment of the term of a patent under 
paragraph (1) shall be reduced by a period equal to the period of time 
during which the applicant failed to engage in reasonable efforts to 
conclude prosecution of the application.  
(ii) With respect to adjustments to patent term made under the 
authority of paragraph (1)(B), an applicant shall be deemed to have failed 
to engage in reasonable efforts to conclude processing or examination of 
an application for the cumulative total of any periods of time in excess of 
3 months that are taken to respond to a notice from the Office making any 
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rejection, objection, argument, or other request, measuring such 3-month 
period from the date the notice was given or mailed to the applicant.  
(iii) The Director shall prescribe regulations establishing the 
circumstances that constitute a failure of an applicant to engage in 
reasonable efforts to conclude processing or examination of an 
application.  
(3) Procedures for patent term adjustment determination.--  
(A) The Director shall prescribe regulations establishing procedures for 
the application for and determination of patent term adjustments under this 
subsection.  
(B) Under the procedures established under subparagraph (A), the Director 
shall--  
(i) make a determination of the period of any patent term 
adjustment under this subsection, and shall transmit a notice of that 
determination with the written notice of allowance of the application 
under section 151no later than the date of issuance of the patent; and  
(ii) provide the applicant one opportunity to request 
reconsideration of any patent term adjustment determination made by the 
Director.  
(C) The Director shall reinstate all or part of the cumulative period of time 
of an adjustment under paragraph (2)(C) if the applicant, prior to the issuance of 
the patent, makes a showing that, in spite of all due care, the applicant was unable 
to respond within the 3-month period, but in no case shall more than three 
additional months for each such response beyond the original 3-month period be 
reinstated.  
(D) The Director shall proceed to grant the patent after completion of the 
Director's determination of a patent term adjustment under the procedures 
established under this subsection, notwithstanding any appeal taken by the 
applicant of such determination.  
(4) Appeal of patent term adjustment determination.--  
(A) An applicant dissatisfied with a determination made by the Director 
under paragraph (3) shall have remedy the Director’s decision on the 
applicant’s request for reconsideration under paragraph (3)(B)(ii) shall have 
exclusive remedy by a civil action against the Director filed in the United States 
6 
 
District Court for the Eastern District of Virginia within 180 days after the grant 
of the patentthe date of the Director’s decision on the applicant’s request for 
reconsideration. Chapter 7 of title 5 shall apply to such action. Any final 
judgment resulting in a change to the period of adjustment of the patent term shall 
be served on the Director, and the Director shall thereafter alter the term of the 
patent to reflect such change.  
(B) The determination of a patent term adjustment under this subsection 
shall not be subject to appeal or challenge by a third party prior to the grant of the 
patent.  
 
Analysis: Under H.R. 6621, patent term adjustments would be calculated at issuance rather than 
at the notice of allowance.  Also, for international applications, patent term adjustment 
calculations would begin with the “commencement of the national stage under Section 371” 
rather than as of the date on which an international application fulfills the requirements of 35 




B.  H.R. 6621 section 1(i): 
  
IMPROPER APPLICANT.—Section 373 of title 35, United States Code, and the item 
relating to that section in the table of sections for chapter 37 of such title, are repealed. 
 
 
Analysis: Section 373 reads: 
An international application designating the United States, shall not be accepted 
by the Patent and Trademark Office for the national stage if it was filed by anyone 
not qualified under chapter 11 to be an applicant for the purpose of filing a 
national application in the United States. Such international applications shall not 
serve as the basis for the benefit of an earlier filing date under section 120 in a 
subsequently filed application, but may serve as the basis for a claim of the right 
of priority under subsections (a) through (d) of section 119, if the United States 
was not the sole country designated in such international application. 
If eliminated by H.R. 6621, foreign inventors and entities would be able to file international PCT 
applications in the United States.  Under current law, this is only permitted when at least one of 




C.  H.R. 6621 section 1(l): 
PATENT AND TRADEMARK PUBLIC ADVISORY COMMITTEES.— 
(1) IN GENERAL.—Section 5(a) of title 35, United States Code, is amended— 
(A) in paragraph (1), by striking ‘‘Members of’’ and all that follows through 
‘‘such appointments.’’ and inserting the following: ‘‘In each year, 3 members shall be 
appointed to each Advisory Committee for 3-year terms that shall begin on May 1 of that 
year. Any vacancy on an Advisory Committee shall be filled within 90 days after it 
occurs. A new member who is appointed to fill a vacancy shall be appointed to serve for 
the remainder of the predecessor’s term.’’; 
(B) by striking paragraph (2) and inserting the following: 
‘‘(2) CHAIRMAN.—The Secretary of Commerce, in consultation with the Director, shall 
designate a Chair and Vice Chair of each Advisory Committee from among the members 
appointed under paragraph (1). Each Chair and Vice Chair shall serve for a 1-year term 
beginning on May 1 of the year in which he or she is so designated. If the Chair resigns before 
the completion of his or her term or is otherwise unable to exercise the functions of the Chair, the 
Vice Chair shall exercise the functions of the Chair.’’; and 
(C) by striking paragraph (3). 
(2) TRANSITION.— 
(A) IN GENERAL.—The Secretary of Commerce shall, in the Secretary’s 
discretion, determine the time and manner in which the amendments made by paragraph 
(1) shall take effect, except that, in each year following the year in which this Act is 
enacted, 3 members shall be appointed to each Advisory Committee (to which such 
amendments apply) for 3-year terms that begin on May 1 of that year, in accordance with 
section 5(a) of title 35, United States Code, as amended by paragraph (1) of this 
subsection. 
(B) DEEMED TERMINATION OF TERMS.— In order to implement the 
amendments made by paragraph (1), the Secretary of Commerce may determine that the 
term of an existing member of an Advisory Committee under section 5 of title 35, United 
States Code, shall be deemed to terminate on May 1 of a year beginning after the date of 
the enactment of this Act, regardless of whether May 1 is before or after the date on 






Resulting Redline of Section 5(a): 
(a) Establishment of Public Advisory Committees.-- 
(1) Appointment.--The United States Patent and Trademark Office shall have a 
Patent Public Advisory Committee and a Trademark Public Advisory Committee, each of 
which shall have nine voting members who shall be appointed by the Secretary of 
Commerce and serve at the pleasure of the Secretary of Commerce. Members of each 
Public Advisory Committee shall be appointed for a term of 3 years, except that of the 
members first appointed, three shall be appointed for a term of 1 year, and three shall be 
appointed for a term of 2 years. In making appointments to each Committee, the 
Secretary of Commerce shall consider the risk of loss of competitive advantage in 
international commerce or other harm to United States companies as a result of such 
appointmentsIn each year, 3 members shall be appointed to each Advisory 
Committee for 3-year terms that shall begin on May 1 of that year. Any vacancy on 
an Advisory Committee shall be filled within 90 days after it occurs. A new member 
who is appointed to fill a vacancy shall be appointed to serve for the remainder of 
the predecessor’s term.  
(2) Chair.--The Secretary shall designate a chair of each Advisory Committee, 
whose term as chair shall be for 3 years. 
(2) CHAIRMAN.—The Secretary of Commerce, in consultation with the 
Director, shall designate a Chair and Vice Chair of each Advisory Committee from 
among the members appointed under paragraph (1). Each Chair and Vice Chair 
shall serve for a 1-year term beginning on May 1 of the year in which he or she is so 
designated. If the Chair resigns before the completion of his or her term or is 
otherwise unable to exercise the functions of the Chair, the Vice Chair shall exercise 
the functions of the Chair.  
(3) Timing of appointments.--Initial appointments to each Advisory Committee 
shall be made within 3 months after the effective date of the Patent and Trademark Office 
Efficiency Act. Vacancies shall be filled within 3 months after they occur.  
 
Analysis:  Under H.R. 6621, public advisory committee terms would begin on May 1 and 
appointment decisions would no longer need to consider “the risk of loss of competitive 
advantage in international commerce or other harm to United States companies as a result of 
such appointments.”  Each committee would have a Vice Chair in addition to a Chair, and the 




D. H.R. 6621 section 1(m): 
EFFECTIVE DATE OF URUGUAY ROUND AGREEMENTS ACT.— 
(1) CERTAIN PATENT APPLICATIONS.—Notwithstanding section 534(b)(1) of the 
Uruguay Round Agreements Act (35 U.S.C. 154 note), section 154(a) of title 35, United States 
Code, as amended by section 532 of the Uruguay Round Agreements Act (Public Law 103–465; 
108 Stat. 4809), shall apply, and section 154(c)(1) of title 35, United States Code, shall not 
apply, to any application that is— 
(A) filed before the date that is 6 months after the date of the enactment of the 
Uruguay Round Agreements Act; and 
(B) pending on a date that is 1 year or more after the date of the enactment of this 
Act. 
(2) EFFECTIVE DATE.—This subsection shall take effect on the date that is 1 year after 
the date of the enactment of this Act and shall apply to any original plant or utility patent 
application that is pending on or after that effective date. 
 
Analysis:  Patent applications (i) filed before June 8, 1995 and (ii) pending one year after the 
enactment of H.R. 6621 (i.e., late 2013 at the earliest) would receive a post-TRIPS term of 20 
years from filing, rather than the pre-TRIPS term of 17 years from issue that they are entitled to 
under current law.  As a result, many would either “expire” before issue, or issue with less than 2 
years of term remaining.  Bottom line: If enacted, HR 6621 will effectively kill many pending 
patent applications filed pre-TRIPS.  
Update: Hal Wegner reports as of December 17, 2012 that this section has been replaced with a 





II. REDLINE OF H.R.1249, ENACTED AS LEAHY-SMITH AMERICA INVENTS ACT 
 
One Hundred Twelfth Congress 
of the 
United States of America 
An Act 
To amend title 35, United States Code, to provide for patent reform. 
Be it enacted by the Senate and House of Representatives of the United States of America 
in Congress assembled, 
SECTION 1. SHORT TITLE; TABLE OF CONTENTS. 
(a) Short Title- This Act may be cited as the ‘Leahy-Smith America Invents Act’. 
(b) Table of Contents- The table of contents for this Act is as follows: 
Sec. 1. Short title; table of contents. 
Sec. 2. Definitions. 
Sec. 3. First inventor to file. 
Sec. 4. Inventor’s oath or declaration. 
Sec. 5. Defense to infringement based on prior commercial use. 
Sec. 6. Post-grant review proceedings. 
Sec. 7. Patent Trial and Appeal Board. 
Sec. 8. Preissuance submissions by third parties. 
Sec. 9. Venue. 
Sec. 10. Fee setting authority. 
Sec. 11. Fees for patent services. 
Sec. 12. Supplemental examination. 
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Sec. 13. Funding agreements. 
Sec. 14. Tax strategies deemed within the prior art. 
Sec. 15. Best mode requirement. 
Sec. 16. Marking. 
Sec. 17. Advice of counsel. 
Sec. 18. Transitional program for covered business method patents. 
Sec. 19. Jurisdiction and procedural matters. 
Sec. 20. Technical amendments. 
Sec. 21. Travel expenses and payment of administrative judges. 
Sec. 22. Patent and Trademark Office funding. 
Sec. 23. Satellite offices. 
Sec. 24. Designation of Detroit satellite office. 
Sec. 25. Priority examination for important technologies. 
Sec. 26. Study on implementation. 
Sec. 27. Study on genetic testing. 
Sec. 28. Patent Ombudsman Program for small business concerns. 
Sec. 29. Establishment of methods for studying the diversity of applicants. 
Sec. 30. Sense of Congress. 
Sec. 31. USPTO study on international patent protections for small businesses. 
Sec. 32. Pro bono program. 
Sec. 33. Limitation on issuance of patents. 
Sec. 34. Study of patent litigation. 
Sec. 35. Effective date. 
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Sec. 36. Budgetary effects. 
Sec. 37. Calculation of 60-day period for application of patent term extension. 
SEC. 2. DEFINITIONS. 
In this Act: 
(1) DIRECTOR- The term ‘Director’ means the Under Secretary of Commerce 
for Intellectual Property and Director of the United States Patent and Trademark 
Office. 
(2) OFFICE- The term ‘Office’ means the United States Patent and Trademark 
Office. 
(3) PATENT PUBLIC ADVISORY COMMITTEE- The term ‘Patent Public 
Advisory Committee’ means the Patent Public Advisory Committee established 
under section 5(a) of title 35, United States Code. 
(4) TRADEMARK ACT OF 1946- The term ‘Trademark Act of 1946’ means the 
Act entitled ‘An Act to provide for the registration and protection of trademarks 
used in commerce, to carry out the provisions of certain international conventions, 
and for other purposes’, approved July 5, 1946 (15 U.S.C. 1051 et seq.) 
(commonly referred to as the ‘Trademark Act of 1946’ or the ‘Lanham Act’). 
(5) TRADEMARK PUBLIC ADVISORY COMMITTEE- The term ‘Trademark 
Public Advisory Committee’ means the Trademark Public Advisory Committee 
established under section 5(a) of title 35, United States Code. 
SEC. 3. FIRST INVENTOR TO FILE. 
(a) Definitions- Section 100 of title 35, United States Code, is amended-- 
(1) in subsection (e), by striking ‘or inter partes reexamination under section 311’; 
and 
(2) by adding at the end the following: 
‘(f) The term ‘inventor’ means the individual or, if a joint invention, the 
individuals collectively who invented or discovered the subject matter of the 
invention. 
‘(g) The terms ‘joint inventor’ and ‘coinventor’ mean any 1 of the individuals 
who invented or discovered the subject matter of a joint invention. 
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‘(h) The term ‘joint research agreement’ means a written contract, grant, or 
cooperative agreement entered into by 2 or more persons or entities for the 
performance of experimental, developmental, or research work in the field of the 
claimed invention. 
‘(i)(1) The term ‘effective filing date’ for a claimed invention in a patent or 
application for patent means-- 
‘(A) if subparagraph (B) does not apply, the actual filing date of the patent 
or the application for the patent containing a claim to the invention; or 
‘(B) the filing date of the earliest application for which the patent or 
application is entitled, as to such invention, to a right of priority under 
section 119, 365(a), or 365(b) or to the benefit of an earlier filing date 
under section 120, 121, or 365(c). 
‘(2) The effective filing date for a claimed invention in an application for reissue 
or reissued patent shall be determined by deeming the claim to the invention to 
have been contained in the patent for which reissue was sought. 
‘(j) The term ‘claimed invention’ means the subject matter defined by a claim in a 
patent or an application for a patent.’. 
(b) Conditions for Patentability- 
(1) IN GENERAL- Section 102 of title 35, United States Code, is amended to 
read as follows: 
-‘Sec. 102. Conditions for patentability; novelty 
‘(a) Novelty; Prior Art- A person shall be entitled to a patent unless-- 
‘(1) the claimed invention was patented, described in a printed publication, 
or in public use, on sale, or otherwise available to the public before the 
effective filing date of the claimed invention; or 
‘(2) the claimed invention was described in a patent issued under section 
151, or in an application for patent published or deemed published under 
section 122(b), in which the patent or application, as the case may be, 
names another inventor and was effectively filed before the effective filing 
date of the claimed invention. 
‘(b) Exceptions- 
‘(1) DISCLOSURES MADE 1 YEAR OR LESS BEFORE THE 
EFFECTIVE FILING DATE OF THE CLAIMED INVENTION- A 
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disclosure made 1 year or less before the effective filing date of a claimed 
invention shall not be prior art to the claimed invention under subsection 
(a)(1) if-- 
‘(A) the disclosure was made by the inventor or joint inventor or 
by another who obtained the subject matter disclosed directly or 
indirectly from the inventor or a joint inventor; or 
‘(B) the subject matter disclosed had, before such disclosure, been 
publicly disclosed by the inventor or a joint inventor or another 
who obtained the subject matter disclosed directly or indirectly 
from the inventor or a joint inventor. 
‘(2) DISCLOSURES APPEARING IN APPLICATIONS AND 
PATENTS- A disclosure shall not be prior art to a claimed invention 
under subsection (a)(2) if-- 
‘(A) the subject matter disclosed was obtained directly or 
indirectly from the inventor or a joint inventor; 
‘(B) the subject matter disclosed had, before such subject matter 
was effectively filed under subsection (a)(2), been publicly 
disclosed by the inventor or a joint inventor or another who 
obtained the subject matter disclosed directly or indirectly from the 
inventor or a joint inventor; or 
‘(C) the subject matter disclosed and the claimed invention, not 
later than the effective filing date of the claimed invention, were 
owned by the same person or subject to an obligation of 
assignment to the same person. 
‘(c) Common Ownership Under Joint Research Agreements- Subject matter 
disclosed and a claimed invention shall be deemed to have been owned by the 
same person or subject to an obligation of assignment to the same person in 
applying the provisions of subsection (b)(2)(C) if-- 
‘(1) the subject matter disclosed was developed and the claimed invention 
was made by, or on behalf of, 1 or more parties to a joint research 
agreement that was in effect on or before the effective filing date of the 
claimed invention; 
‘(2) the claimed invention was made as a result of activities undertaken 
within the scope of the joint research agreement; and 
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‘(3) the application for patent for the claimed invention discloses or is 
amended to disclose the names of the parties to the joint research 
agreement. 
‘(d) Patents and Published Applications Effective as Prior Art- For purposes of 
determining whether a patent or application for patent is prior art to a claimed 
invention under subsection (a)(2), such patent or application shall be considered 
to have been effectively filed, with respect to any subject matter described in the 
patent or application-- 
‘(1) if paragraph (2) does not apply, as of the actual filing date of the 
patent or the application for patent; or 
‘(2) if the patent or application for patent is entitled to claim a right of 
priority under section 119, 365(a), or 365(b), or to claim the benefit of an 
earlier filing date under section 120, 121, or 365(c), based upon 1 or more 
prior filed applications for patent, as of the filing date of the earliest such 
application that describes the subject matter.’. 
(2) CONTINUITY OF INTENT UNDER THE CREATE ACT- The 
enactment of section 102(c) of title 35, United States Code, under 
paragraph (1) of this subsection is done with the same intent to promote 
joint research activities that was expressed, including in the legislative 
history, through the enactment of the Cooperative Research and 
Technology Enhancement Act of 2004 (Public Law 108-453; the 
‘CREATE Act’), the amendments of which are stricken by subsection (c) 
of this section. The United States Patent and Trademark Office shall 
administer section 102(c) of title 35, United States Code, in a manner 
consistent with the legislative history of the CREATE Act that was 
relevant to its administration by the United States Patent and Trademark 
Office. 
(3) CONFORMING AMENDMENT- The item relating to section 102 in 
the table of sections for chapter 10 of title 35, United States Code, is 
amended to read as follows: 
‘102. Conditions for patentability; novelty.’. 
(c) Conditions for Patentability; Nonobvious Subject Matter- Section 103 of title 
35, United States Code, is amended to read as follows: 
-‘Sec. 103. Conditions for patentability; non-obvious subject matter 
‘A patent for a claimed invention may not be obtained, notwithstanding that the 
claimed invention is not identically disclosed as set forth in section 102, if the 
differences between the claimed invention and the prior art are such that the 
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claimed invention as a whole would have been obvious before the effective filing 
date of the claimed invention to a person having ordinary skill in the art to which 
the claimed invention pertains. Patentability shall not be negated by the manner in 
which the invention was made.’. 
(d) Repeal of Requirements for Inventions Made Abroad- Section 104 of title 35, 
United States Code, and the item relating to that section in the table of sections for 
chapter 10 of title 35, United States Code, are repealed. 
(e) Repeal of Statutory Invention Registration- 
(1) IN GENERAL- Section 157 of title 35, United States Code, and the 
item relating to that section in the table of sections for chapter 14 of title 
35, United States Code, are repealed. 
(2) REMOVAL OF CROSS REFERENCES- Section 111(b)(8) of title 35, 
United States Code, is amended by striking ‘sections 115, 131, 135, and 
157’ and inserting ‘sections 131 and 135’. 
(3) EFFECTIVE DATE- The amendments made by this subsection shall 
take effect upon the expiration of the 18-month period beginning on the 
date of the enactment of this Act, and shall apply to any request for a 
statutory invention registration filed on or after that effective date. 
(f) Earlier Filing Date for Inventor and Joint Inventor- Section 120 of title 35, 
United States Code, is amended by striking ‘which is filed by an inventor or 
inventors named’ and inserting ‘which names an inventor or joint inventor’. 
(g) Conforming Amendments- 
(1) RIGHT OF PRIORITY- Section 172 of title 35, United States Code, is 
amended by striking ‘and the time specified in section 102(d)’. 
(2) LIMITATION ON REMEDIES- Section 287(c)(4) of title 35, United 
States Code, is amended by striking ‘the earliest effective filing date of 
which is prior to’ and inserting ‘which has an effective filing date before’. 
(3) INTERNATIONAL APPLICATION DESIGNATING THE UNITED 
STATES: EFFECT- Section 363 of title 35, United States Code, is 
amended by striking ‘except as otherwise provided in section 102(e) of 
this title’. 
(4) PUBLICATION OF INTERNATIONAL APPLICATION: EFFECT- 
Section 374 of title 35, United States Code, is amended by striking 
‘sections 102(e) and 154(d)’ and inserting ‘section 154(d)’. 
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(5) PATENT ISSUED ON INTERNATIONAL APPLICATION: 
EFFECT- The second sentence of section 375(a) of title 35, United States 
Code, is amended by striking ‘Subject to section 102(e) of this title, such’ 
and inserting ‘Such’. 
(6) LIMIT ON RIGHT OF PRIORITY- Section 119(a) of title 35, United 
States Code, is amended by striking ‘; but no patent shall be granted’ and 
all that follows through ‘one year prior to such filing’. 
(7) INVENTIONS MADE WITH FEDERAL ASSISTANCE- Section 
202(c) of title 35, United States Code, is amended-- 
(A) in paragraph (2)-- 
(i) by striking ‘publication, on sale, or public use,’ and all 
that follows through ‘obtained in the United States’ and 
inserting ‘the 1-year period referred to in section 102(b) 
would end before the end of that 2-year period’; and 
(ii) by striking ‘prior to the end of the statutory’ and 
inserting ‘before the end of that 1-year’; and 
(B) in paragraph (3), by striking ‘any statutory bar date that may 
occur under this title due to publication, on sale, or public use’ and 
inserting ‘the expiration of the 1-year period referred to in section 
102(b)’. 
(h) Derived Patents- 
(1) IN GENERAL- Section 291 of title 35, United States Code, is 
amended to read as follows: 
-‘Sec. 291. Derived Patents 
‘(a) In General- The owner of a patent may have relief by civil action against the 
owner of another patent that claims the same invention and has an earlier effective 
filing date, if the invention claimed in such other patent was derived from the 
inventor of the invention claimed in the patent owned by the person seeking relief 
under this section. 
‘(b) Filing Limitation- An action under this section may be filed only before the 
end of the 1-year period beginning on the date of the issuance of the first patent 
containing a claim to the allegedly derived invention and naming an individual 
alleged to have derived such invention as the inventor or joint inventor.’. 
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(2) CONFORMING AMENDMENT- The item relating to section 291 in 
the table of sections for chapter 29 of title 35, United States Code, is 
amended to read as follows: 
‘291. Derived patents.’. 
(i) Derivation Proceedings- Section 135 of title 35, United States Code, is 
amended to read as follows: 
-‘Sec. 135. Derivation proceedings 
‘(a) Institution of Proceeding— 
‘‘(1) IN GENERAL.—An applicant for patent may file a petition with 
respect to an invention to institute a derivation proceeding in the Office. The 
petition shall set forth with particularity the basis for finding that an 
inventorindividual named in an earlier application as the inventor or a joint 
inventor derived the claimedsuch invention from an inventorindividual named 
in the petitioner’s application as the inventor or a joint inventor and, without 
authorization, the earlier application claiming such invention was filed. Any such 
petition may be filed only within the 1-year period beginning on the date of 
the first publication of a claim to an invention that is the same or 
substantially the same as the earlier application’s claim to the invention, shall 
be made under oath, and shall be supported by substantial evidence. 
Whenever the Director determines that a petition filed under this subsection 
demonstrates that the standards for instituting a derivation proceeding are met, the 
Director may institute a derivation proceeding.  
‘‘(2) TIME FOR FILING.—A petition under this section with respect 
to an invention that is the same or substantially the same invention as a claim 
contained in a patent issued on an earlier application, or contained in an 
earlier application when published or deemed published under section 
122(b), may not be filed unless such petition is filed during the 1-year period 
following the date on which the patent containing such claim was granted or 
the earlier application containing such claim was published, whichever is 
earlier. 
‘‘(3) EARLIER APPLICATION.—For purposes of this section, an 
application shall not be deemed to be an earlier application with respect to 
an invention, relative to another application, unless a claim to the invention 
was or could have been made in such application having an effective filing 
date that is earlier than the effective filing date of any claim to the invention 
that was or could have been made in such other application. 
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‘‘(4) NO APPEAL.—AThe determination by the Director whether to 
institute a derivation proceeding under paragraph (1) shall be final and not 
nappealable.”  
[Analysis: HR 6621 expands and reorganizes the AIA’s statutory language 
pertaining to derivation proceedings.  Overall, the changes appear to be non-
substantive.] 
‘(b) Determination by Patent Trial and Appeal Board- In a derivation proceeding 
instituted under subsection (a), the Patent Trial and Appeal Board shall determine 
whether an inventor named in the earlier application derived the claimed 
invention from an inventor named in the petitioner’s application and, without 
authorization, the earlier application claiming such invention was filed. In 
appropriate circumstances, the Patent Trial and Appeal Board may correct the 
naming of the inventor in any application or patent at issue. The Director shall 
prescribe regulations setting forth standards for the conduct of derivation 
proceedings, including requiring parties to provide sufficient evidence to prove 
and rebut a claim of derivation. 
‘(c) Deferral of Decision- The Patent Trial and Appeal Board may defer action on 
a petition for a derivation proceeding until the expiration of the 3-month period 
beginning on the date on which the Director issues a patent that includes the 
claimed invention that is the subject of the petition. The Patent Trial and Appeal 
Board also may defer action on a petition for a derivation proceeding, or stay the 
proceeding after it has been instituted, until the termination of a proceeding under 
chapter 30, 31, or 32 involving the patent of the earlier applicant. 
‘(d) Effect of Final Decision- The final decision of the Patent Trial and Appeal 
Board, if adverse to claims in an application for patent, shall constitute the final 
refusal by the Office on those claims. The final decision of the Patent Trial and 
Appeal Board, if adverse to claims in a patent, shall, if no appeal or other review 
of the decision has been or can be taken or had, constitute cancellation of those 
claims, and notice of such cancellation shall be endorsed on copies of the patent 
distributed after such cancellation. 
‘(e) Settlement- Parties to a proceeding instituted under subsection (a) may 
terminate the proceeding by filing a written statement reflecting the agreement of 
the parties as to the correct inventorscorrect inventor of the claimed invention 
in dispute. Unless the Patent Trial and Appeal Board finds the agreement to be 
inconsistent with the evidence of record, if any, it shall take action consistent with 
the agreement. Any written settlement or understanding of the parties shall be 
filed with the Director. At the request of a party to the proceeding, the agreement 
or understanding shall be treated as business confidential information, shall be 
kept separate from the file of the involved patents or applications, and shall be 
made available only to Government agencies on written request, or to any person 
on a showing of good cause. 
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[Analysis: Typo correction.] 
‘(f) Arbitration- Parties to a proceeding instituted under subsection (a) may, 
within such time as may be specified by the Director by regulation, determine 
such contest or any aspect thereof by arbitration. Such arbitration shall be 
governed by the provisions of title 9, to the extent such title is not inconsistent 
with this section. The parties shall give notice of any arbitration award to the 
Director, and such award shall, as between the parties to the arbitration, be 
dispositive of the issues to which it relates. The arbitration award shall be 
unenforceable until such notice is given. Nothing in this subsection shall preclude 
the Director from determining the patentability of the claimed inventions involved 
in the proceeding.’. 
(j) Elimination of References to Interferences- (1) Sections 134, 145, 146, 154, 
and 305 of title 35, United States Code, are each amended by striking ‘Board of 
Patent Appeals and Interferences’ each place it appears and inserting ‘Patent Trial 
and Appeal Board’. 
(2)(A) Section 146 of title 35, United States Code, is amended-- 
(i) by striking ‘an interference’ and inserting ‘a derivation 
proceeding’; and 
(ii) by striking ‘the interference’ and inserting ‘the derivation 
proceeding’. 
(B) The subparagraph heading for section 154(b)(1)(C) of title 35, United 
States Code, is amended to read as follows: 
‘(C) GUARANTEE OF ADJUSTMENTS FOR DELAYS 
DUE TO DERIVATION PROCEEDINGS, SECRECY 
ORDERS, AND APPEALS- ’. 
(3) The section heading for section 134 of title 35, United States Code, is 
amended to read as follows: 
-‘Sec. 134. Appeal to the Patent Trial and Appeal Board’. 
(4) The section heading for section 146 of title 35, United States Code, is amended to 
read as follows: 
-‘Sec. 146. Civil action in case of derivation proceeding’. 
(5) The items relating to sections 134 and 135 in the table of sections for chapter 12 of 
title 35, United States Code, are amended to read as follows: 
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‘134. Appeal to the Patent Trial and Appeal Board. 
‘135. Derivation proceedings.’. 
(6) The item relating to section 146 in the table of sections for chapter 13 of title 35, 
United States Code, is amended to read as follows: 
‘146. Civil action in case of derivation proceeding.’. 
[H.R. 6621, Section 1(k)(3) reads: “REVIEW OF INTERFERENCE DECISIONS.—The 
provisions of sections 6 and 141 of title 35, United States Code, and section 1295(a)(4)(A) of 
title 28, United States Code, as in effect on September 15, 2012, shall apply to interference 
proceedings that are declared after September 15, 2012, under section 135 of title 35, 
United States Code, as in effect before the effective date under section 3(n) of the Leahy-
Smith America Invents Act. The Patent Trial and Appeal Board may be deemed to be the 
Board of Patent Appeals and Interferences for purposes of such interference proceedings.” 
Analysis: H.R. 6621 makes clear that pre-AIA law regarding interferences—not post-AIA law 
regarding derivation proceedings—applies to patent applications filed before the effective date of 
the AIA’s “first to file” provisions.] 
(k) Statute of Limitations- 
(1) IN GENERAL- Section 32 of title 35, United States Code, is amended by 
inserting between the third and fourth sentences the following: ‘A proceeding 
under this section shall be commenced not later than the earlier of either the date 
that is 10 years after the date on which the misconduct forming the basis for the 
proceeding occurred, or 1 year after the date on which the misconduct forming the 
basis for the proceeding is made known to an officer or employee of the Office as 
prescribed in the regulations established under section 2(b)(2)(D).’. 
(2) REPORT TO CONGRESS- The Director shall provide on a biennial basis to 
the Judiciary Committees of the Senate and House of Representatives a report 
providing a short description of incidents made known to an officer or employee 
of the Office as prescribed in the regulations established under section 2(b)(2)(D) 
of title 35, United States Code, that reflect substantial evidence of misconduct 
before the Office but for which the Office was barred from commencing a 
proceeding under section 32 of title 35, United States Code, by the time limitation 
established by the fourth sentence of that section. 
(3) EFFECTIVE DATE- The amendment made by paragraph (1) shall apply in 
any case in which the time period for instituting a proceeding under section 32 of 
title 35, United States Code, had not lapsed before the date of the enactment of 
this Act. 
(l) Small Business Study- 
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(1) DEFINITIONS- In this subsection-- 
(A) the term ‘Chief Counsel’ means the Chief Counsel for Advocacy of 
the Small Business Administration; 
(B) the term ‘General Counsel’ means the General Counsel of the United 
States Patent and Trademark Office; and 
(C) the term ‘small business concern’ has the meaning given that term 
under section 3 of the Small Business Act (15 U.S.C. 632). 
(2) STUDY- 
(A) IN GENERAL- The Chief Counsel, in consultation with the General 
Counsel, shall conduct a study of the effects of eliminating the use of dates 
of invention in determining whether an applicant is entitled to a patent 
under title 35, United States Code. 
(B) AREAS OF STUDY- The study conducted under subparagraph (A) 
shall include examination of the effects of eliminating the use of invention 
dates, including examining-- 
(i) how the change would affect the ability of small business 
concerns to obtain patents and their costs of obtaining patents; 
(ii) whether the change would create, mitigate, or exacerbate any 
disadvantages for applicants for patents that are small business 
concerns relative to applicants for patents that are not small 
business concerns, and whether the change would create any 
advantages for applicants for patents that are small business 
concerns relative to applicants for patents that are not small 
business concerns; 
(iii) the cost savings and other potential benefits to small business 
concerns of the change; and 
(iv) the feasibility and costs and benefits to small business 
concerns of alternative means of determining whether an applicant 
is entitled to a patent under title 35, United States Code. 
(3) REPORT- Not later than the date that is 1 year after the date of the enactment 
of this Act, the Chief Counsel shall submit to the Committee on Small Business 
and Entrepreneurship and the Committee on the Judiciary of the Senate and the 
Committee on Small Business and the Committee on the Judiciary of the House 
of Representatives a report on the results of the study under paragraph (2). 
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(m) Report on Prior User Rights- 
(1) IN GENERAL- Not later than the end of the 4-month period beginning on the 
date of the enactment of this Act, the Director shall report, to the Committee on 
the Judiciary of the Senate and the Committee on the Judiciary of the House of 
Representatives, the findings and recommendations of the Director on the 
operation of prior user rights in selected countries in the industrialized world. The 
report shall include the following: 
(A) A comparison between patent laws of the United States and the laws 
of other industrialized countries, including members of the European 
Union and Japan, Canada, and Australia. 
(B) An analysis of the effect of prior user rights on innovation rates in the 
selected countries. 
(C) An analysis of the correlation, if any, between prior user rights and 
start-up enterprises and the ability to attract venture capital to start new 
companies. 
(D) An analysis of the effect of prior user rights, if any, on small 
businesses, universities, and individual inventors. 
(E) An analysis of legal and constitutional issues, if any, that arise from 
placing trade secret law in patent law. 
(F) An analysis of whether the change to a first-to-file patent system 
creates a particular need for prior user rights. 
(2) CONSULTATION WITH OTHER AGENCIES- In preparing the report 
required under paragraph (1), the Director shall consult with the United States 
Trade Representative, the Secretary of State, and the Attorney General. 
(n) Effective Date- 
(1) IN GENERAL- Except as otherwise provided in this section, the amendments 
made by this section shall take effect upon the expiration of the 18-month period 
beginning on the date of the enactment of this Act, and shall apply to any 
application for patent, and to any patent issuing thereon, that contains or 
contained at any time-- 
(A) a claim to a claimed invention that has an effective filing date as 
defined in section 100(i) of title 35, United States Code, that is on or after 
the effective date described in this paragraph; or 
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(B) a specific reference under section 120, 121, or 365(c) of title 35, 
United States Code, to any patent or application that contains or contained 
at any time such a claim. 
(2) INTERFERING PATENTS- The provisions of sections 102(g), 135, and 291 
of title 35, United States Code, as in effect on the day before the effective date set 
forth in paragraph (1) of this subsection, shall apply to each claim of an 
application for patent, and any patent issued thereon, for which the amendments 
made by this section also apply, if such application or patent contains or contained 
at any time-- 
(A) a claim to an invention having an effective filing date as defined in 
section 100(i) of title 35, United States Code, that occurs before the 
effective date set forth in paragraph (1) of this subsection; or 
(B) a specific reference under section 120, 121, or 365(c) of title 35, 
United States Code, to any patent or application that contains or contained 
at any time such a claim. 
(o) Sense of Congress- It is the sense of the Congress that converting the United States 
patent system from ‘first to invent’ to a system of ‘first inventor to file’ will promote the 
progress of science and the useful arts by securing for limited times to inventors the 
exclusive rights to their discoveries and provide inventors with greater certainty 
regarding the scope of protection provided by the grant of exclusive rights to their 
discoveries. 
(p) Sense of Congress- It is the sense of the Congress that converting the United States 
patent system from ‘first to invent’ to a system of ‘first inventor to file’ will improve the 
United States patent system and promote harmonization of the United States patent 
system with the patent systems commonly used in nearly all other countries throughout 
the world with whom the United States conducts trade and thereby promote greater 
international uniformity and certainty in the procedures used for securing the exclusive 
rights of inventors to their discoveries. 
SEC. 4. INVENTOR’S OATH OR DECLARATION. 
(a) Inventor’s Oath or Declaration- 
(1) IN GENERAL- Section 115 of title 35, United States Code, is amended to 
read as follows: 
-‘Sec. 115. Inventor’s oath or declaration 
‘(a) Naming the Inventor; Inventor’s Oath or Declaration- An application for 
patent that is filed under section 111(a) or commences the national stage under 
section 371 shall include, or be amended to include, the name of the inventor for 
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any invention claimed in the application. Except as otherwise provided in this 
section, each individual who is the inventor or a joint inventor of a claimed 
invention in an application for patent shall execute an oath or declaration in 
connection with the application. 
‘(b) Required Statements- An oath or declaration under subsection (a) shall 
contain statements that-- 
‘(1) the application was made or was authorized to be made by the affiant 
or declarant; and 
‘(2) such individual believes himself or herself to be the original inventor 
or an original joint inventor of a claimed invention in the application. 
‘(c) Additional Requirements- The Director may specify additional information 
relating to the inventor and the invention that is required to be included in an oath 
or declaration under subsection (a). 
‘(d) Substitute Statement- 
‘(1) IN GENERAL- In lieu of executing an oath or declaration under 
subsection (a), the applicant for patent may provide a substitute statement 
under the circumstances described in paragraph (2) and such additional 
circumstances that the Director may specify by regulation. 
‘(2) PERMITTED CIRCUMSTANCES- A substitute statement under 
paragraph (1) is permitted with respect to any individual who-- 
‘(A) is unable to file the oath or declaration under subsection (a) 
because the individual-- 
‘(i) is deceased; 
‘(ii) is under legal incapacity; or 
‘(iii) cannot be found or reached after diligent effort; or 
‘(B) is under an obligation to assign the invention but has refused 
to make the oath or declaration required under subsection (a). 
‘(3) CONTENTS- A substitute statement under this subsection shall-- 




‘(B) set forth the circumstances representing the permitted basis 
for the filing of the substitute statement in lieu of the oath or 
declaration under subsection (a); and 
‘(C) contain any additional information, including any showing, 
required by the Director. 
‘(e) Making Required Statements in Assignment of Record- An individual who is 
under an obligation of assignment of an application for patent may include the 
required statements under subsections (b) and (c) in the assignment executed by 
the individual, in lieu of filing such statements separately. 
‘(f) Time for Filing- A notice of allowance under section 151 may be provided 
to an applicant for patent only if the applicant for patent has filed each 
required oath or declaration under subsection (a) or has filed a substitute 
statement under subsection (d) or recorded an assignment meeting the 
requirements of subsection (e). 
‘‘(f) TIME FOR FILING.—The applicant for patent shall provide each 
required oath or declaration under subsection (a), substitute statement under 
subsection (d), or recorded assignment meeting the requirements of 
subsection (e) no later than the date on which the issue fee for the patent is 
paid. 
 
[Analysis: Under H.R. 6621, the inventor’s oath is no longer required before a 
notice of allowance.  The oath can be provided later, when the issue fee is paid.] 
‘(g) Earlier-Filed Application Containing Required Statements or Substitute 
Statement- 
‘(1) EXCEPTION- The requirements under this section shall not apply to 
an individual with respect to an application for patent in which the 
individual is named as the inventor or a joint inventor and whothat claims 
the benefit under section 120, 121, or 365(c) of the filing of an earlier-
filed application, if— 
[Analysis: Typo correction.] 
‘(A) an oath or declaration meeting the requirements of subsection 
(a) was executed by the individual and was filed in connection 
with the earlier-filed application; 
‘(B) a substitute statement meeting the requirements of subsection 
(d) was filed in connection with the earlier filed application with 
respect to the individual; or 
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‘(C) an assignment meeting the requirements of subsection (e) was 
executed with respect to the earlier-filed application by the 
individual and was recorded in connection with the earlier-filed 
application. 
‘(2) COPIES OF OATHS, DECLARATIONS, STATEMENTS, OR 
ASSIGNMENTS- Notwithstanding paragraph (1), the Director may 
require that a copy of the executed oath or declaration, the substitute 
statement, or the assignment filed in connection with the earlier-filed 
application be included in the later-filed application. 
‘(h) Supplemental and Corrected Statements; Filing Additional Statements- 
‘(1) IN GENERAL- Any person making a statement required under this 
section may withdraw, replace, or otherwise correct the statement at any 
time. If a change is made in the naming of the inventor requiring the filing 
of 1 or more additional statements under this section, the Director shall 
establish regulations under which such additional statements may be filed. 
‘(2) SUPPLEMENTAL STATEMENTS NOT REQUIRED- If an 
individual has executed an oath or declaration meeting the requirements of 
subsection (a) or an assignment meeting the requirements of subsection (e) 
with respect to an application for patent, the Director may not thereafter 
require that individual to make any additional oath, declaration, or other 
statement equivalent to those required by this section in connection with 
the application for patent or any patent issuing thereon. 
‘(3) SAVINGS CLAUSE- A patent shall not be invalid or unenforceable 
based upon the failure to comply with a requirement under this section if 
the failure is remedied as provided under paragraph (1). 
‘(i) Acknowledgment of Penalties- Any declaration or statement filed pursuant to 
this section shall contain an acknowledgment that any willful false statement 
made in such declaration or statement is punishable under section 1001 of title 18 
by fine or imprisonment of not more than 5 years, or both.’. 
(2) RELATIONSHIP TO DIVISIONAL APPLICATIONS- Section 121 of 
title 35, United States Code, is amended by striking ‘If a divisional 
application’ and all that follows through ‘inventor.’. 
(3) REQUIREMENTS FOR NONPROVISIONAL APPLICATIONS- 
Section 111(a) of title 35, United States Code, is amended-- 




(B) in the heading for paragraph (3), by inserting ‘OR 
DECLARATION’ after ‘AND OATH’; and 
(C) by inserting ‘or declaration’ after ‘and oath’ each place it 
appears. 
(4) CONFORMING AMENDMENT- The item relating to section 115 in 
the table of sections for chapter 11 of title 35, United States Code, is 
amended to read as follows: 
‘115. Inventor’s oath or declaration.’. 
(b) Filing by Other Than Inventor- 
(1) IN GENERAL- Section 118 of title 35, United States Code, is 
amended to read as follows: 
-‘Sec. 118. Filing by other than inventor 
‘A person to whom the inventor has assigned or is under an obligation to assign 
the invention may make an application for patent. A person who otherwise shows 
sufficient proprietary interest in the matter may make an application for patent on 
behalf of and as agent for the inventor on proof of the pertinent facts and a 
showing that such action is appropriate to preserve the rights of the parties. If the 
Director grants a patent on an application filed under this section by a person 
other than the inventor, the patent shall be granted to the real party in interest and 
upon such notice to the inventor as the Director considers to be sufficient.’. 
(2) CONFORMING AMENDMENT- Section 251 of title 35, United 
States Code, is amended in the third undesignated paragraph by inserting 
‘or the application for the original patent was filed by the assignee of the 
entire interest’ after ‘claims of the original patent’. 
(c) Specification- Section 112 of title 35, United States Code, is amended-- 
(1) in the first undesignated paragraph-- 
(A) by striking ‘The specification’ and inserting ‘(a) In General- 
The specification’; and 
(B) by striking ‘of carrying out his invention’ and inserting ‘or 
joint inventor of carrying out the invention’; 
(2) in the second undesignated paragraph-- 
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(A) by striking ‘The specification’ and inserting ‘(b) Conclusion- 
The specification’; and 
(B) by striking ‘applicant regards as his invention’ and inserting 
‘inventor or a joint inventor regards as the invention’; 
(3) in the third undesignated paragraph, by striking ‘A claim’ and inserting 
‘(c) Form- A claim’; 
(4) in the fourth undesignated paragraph, by striking ‘Subject to the 
following paragraph,’ and inserting ‘(d) Reference in Dependent Forms- 
Subject to subsection (e),’; 
(5) in the fifth undesignated paragraph, by striking ‘A claim’ and inserting 
‘(e) Reference in Multiple Dependent Form- A claim’; and 
(6) in the last undesignated paragraph, by striking ‘An element’ and 
inserting ‘(f) Element in Claim for a Combination- An element’. 
(d) Conforming Amendments- 
(1) Sections 111(b)(1)(A) of title 35, United States Code, is amended by 
striking ‘the first paragraph of section 112 of this title’ and inserting 
‘section 112(a)’. 
(2) Section 111(b)(2) of title 35, United States Code, is amended by 
striking ‘the second through fifth paragraphs of section 112,’ and inserting 
‘subsections (b) through (e) of section 112,’. 
(e) Effective Date- The amendments made by this section shall take effect upon 
the expiration of the 1-year period beginning on the date of the enactment of this 
Act and shall apply to any patent application that is filed on or after that effective 
date. 
SEC. 5. DEFENSE TO INFRINGEMENT BASED ON PRIOR COMMERCIAL USE. 
(a) In General- Section 273 of title 35, United States Code, is amended to read as follows: 
-‘Sec. 273. Defense to infringement based on prior commercial use 
‘(a) In General- A person shall be entitled to a defense under section 282(b) with 
respect to subject matter consisting of a process, or consisting of a machine, 
manufacture, or composition of matter used in a manufacturing or other 
commercial process, that would otherwise infringe a claimed invention being 
asserted against the person if-- 
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‘(1) such person, acting in good faith, commercially used the subject 
matter in the United States, either in connection with an internal 
commercial use or an actual arm’s length sale or other arm’s length 
commercial transfer of a useful end result of such commercial use; and 
‘(2) such commercial use occurred at least 1 year before the earlier of 
either-- 
‘(A) the effective filing date of the claimed invention; or 
‘(B) the date on which the claimed invention was disclosed to the 
public in a manner that qualified for the exception from prior art 
under section 102(b). 
‘(b) Burden of Proof- A person asserting a defense under this section shall have 
the burden of establishing the defense by clear and convincing evidence. 
‘(c) Additional Commercial Uses- 
‘(1) PREMARKETING REGULATORY REVIEW- Subject matter for 
which commercial marketing or use is subject to a premarketing 
regulatory review period during which the safety or efficacy of the subject 
matter is established, including any period specified in section 156(g), 
shall be deemed to be commercially used for purposes of subsection (a)(1) 
during such regulatory review period. 
‘(2) NONPROFIT LABORATORY USE- A use of subject matter by a 
nonprofit research laboratory or other nonprofit entity, such as a university 
or hospital, for which the public is the intended beneficiary, shall be 
deemed to be a commercial use for purposes of subsection (a)(1), except 
that a defense under this section may be asserted pursuant to this 
paragraph only for continued and noncommercial use by and in the 
laboratory or other nonprofit entity. 
‘(d) Exhaustion of Rights- Notwithstanding subsection (e)(1), the sale or other 
disposition of a useful end result by a person entitled to assert a defense under this 
section in connection with a patent with respect to that useful end result shall 
exhaust the patent owner’s rights under the patent to the extent that such rights 
would have been exhausted had such sale or other disposition been made by the 
patent owner. 
‘(e) Limitations and Exceptions- 
‘(1) PERSONAL DEFENSE- 
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‘(A) IN GENERAL- A defense under this section may be asserted 
only by the person who performed or directed the performance of 
the commercial use described in subsection (a), or by an entity that 
controls, is controlled by, or is under common control with such 
person. 
‘(B) TRANSFER OF RIGHT- Except for any transfer to the patent 
owner, the right to assert a defense under this section shall not be 
licensed or assigned or transferred to another person except as an 
ancillary and subordinate part of a good-faith assignment or 
transfer for other reasons of the entire enterprise or line of business 
to which the defense relates. 
‘(C) RESTRICTION ON SITES- A defense under this section, 
when acquired by a person as part of an assignment or transfer 
described in subparagraph (B), may only be asserted for uses at 
sites where the subject matter that would otherwise infringe a 
claimed invention is in use before the later of the effective filing 
date of the claimed invention or the date of the assignment or 
transfer of such enterprise or line of business. 
‘(2) DERIVATION- A person may not assert a defense under this section 
if the subject matter on which the defense is based was derived from the 
patentee or persons in privity with the patentee. 
‘(3) NOT A GENERAL LICENSE- The defense asserted by a person 
under this section is not a general license under all claims of the patent at 
issue, but extends only to the specific subject matter for which it has been 
established that a commercial use that qualifies under this section 
occurred, except that the defense shall also extend to variations in the 
quantity or volume of use of the claimed subject matter, and to 
improvements in the claimed subject matter that do not infringe additional 
specifically claimed subject matter of the patent. 
‘(4) ABANDONMENT OF USE- A person who has abandoned 
commercial use (that qualifies under this section) of subject matter may 
not rely on activities performed before the date of such abandonment in 
establishing a defense under this section with respect to actions taken on 
or after the date of such abandonment. 
‘(5) UNIVERSITY EXCEPTION- 
‘(A) IN GENERAL- A person commercially using subject matter 
to which subsection (a) applies may not assert a defense under this 
section if the claimed invention with respect to which the defense 
is asserted was, at the time the invention was made, owned or 
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subject to an obligation of assignment to either an institution of 
higher education (as defined in section 101(a) of the Higher 
Education Act of 1965 (20 U.S.C. 1001(a)), or a technology 
transfer organization whose primary purpose is to facilitate the 
commercialization of technologies developed by one or more such 
institutions of higher education. 
‘(B) EXCEPTION- Subparagraph (A) shall not apply if any of the 
activities required to reduce to practice the subject matter of the 
claimed invention could not have been undertaken using funds 
provided by the Federal Government. 
‘(f) Unreasonable Assertion of Defense- If the defense under this section is 
pleaded by a person who is found to infringe the patent and who subsequently 
fails to demonstrate a reasonable basis for asserting the defense, the court shall 
find the case exceptional for the purpose of awarding attorney fees under section 
285. 
‘(g) Invalidity- A patent shall not be deemed to be invalid under section 102 or 
103 solely because a defense is raised or established under this section.’. 
(b) Conforming Amendment- The item relating to section 273 in the table of 
sections for chapter 28 of title 35, United States Code, is amended to read as 
follows: 
‘273. Defense to infringement based on prior commercial use.’. 
(c) Effective Date- The amendments made by this section shall apply to any 
patent issued on or after the date of the enactment of this Act. 
SEC. 6. POST-GRANT REVIEW PROCEEDINGS. 
(a) Inter Partes Review- Chapter 31 of title 35, United States Code, is amended to read as 
follows: 
‘CHAPTER 31--INTER PARTES REVIEW 
‘Sec. 
‘311. Inter partes review. 
‘312. Petitions. 
‘313. Preliminary response to petition. 
‘314. Institution of inter partes review. 
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‘315. Relation to other proceedings or actions. 
‘316. Conduct of inter partes review. 
‘317. Settlement. 
‘318. Decision of the Board. 
‘319. Appeal. 
-‘Sec. 311. Inter partes review 
‘(a) In General- Subject to the provisions of this chapter, a person who is not the 
owner of a patent may file with the Office a petition to institute an inter partes 
review of the patent. The Director shall establish, by regulation, fees to be paid by 
the person requesting the review, in such amounts as the Director determines to be 
reasonable, considering the aggregate costs of the review. 
‘(b) Scope- A petitioner in an inter partes review may request to cancel as 
unpatentable 1 or more claims of a patent only on a ground that could be raised 
under section 102 or 103 and only on the basis of prior art consisting of patents or 
printed publications. 
‘(c) Filing Deadline- A petition for inter partes review shall be filed after the later 
of either-- 
‘(1) the date that is 9 months after the grant of a patent or issuance of a 
reissue of a patent; or 
‘(2) if a post-grant review is instituted under chapter 32, the date of the 
termination of such post-grant review. 
[Section 311(c) of title 35, United States Code, shall not apply to a petition to 
institute an inter partes review of a patent that is not a patent described in 
section 3(n)(1) of the Leahy-Smith America Invents Act (35 U.S.C. 100 note). 
 
Analysis: The AIA created a “dead zone” in which patents filed before March 16, 
2013 cannot be challenged in an inter partes proceeding during the first 9 months 
of their term because neither post grant review (which only applies to patent 
issued from applications filed on or after March 16, 2013) nor inter partes review 
(which generally doesn’t apply during the first 9 months after a patent’s issuance) 
applies during that period.  This provision would permit patents issued from 
applications filed under the present first-to-invent regime to be challenged via 
inter partes review during the first 9 months of their term.] 
-‘Sec. 312. Petitions 
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‘(a) Requirements of Petition- A petition filed under section 311 may be 
considered only if-- 
‘(1) the petition is accompanied by payment of the fee established by the 
Director under section 311; 
‘(2) the petition identifies all real parties in interest; 
‘(3) the petition identifies, in writing and with particularity, each claim 
challenged, the grounds on which the challenge to each claim is based, and 
the evidence that supports the grounds for the challenge to each claim, 
including-- 
‘(A) copies of patents and printed publications that the petitioner 
relies upon in support of the petition; and 
‘(B) affidavits or declarations of supporting evidence and opinions, 
if the petitioner relies on expert opinions; 
‘(4) the petition provides such other information as the Director may 
require by regulation; and 
‘(5) the petitioner provides copies of any of the documents required under 
paragraphs (2), (3), and (4) to the patent owner or, if applicable, the 
designated representative of the patent owner. 
‘(b) Public Availability- As soon as practicable after the receipt of a petition 
under section 311, the Director shall make the petition available to the public. 
-‘Sec. 313. Preliminary response to petition 
‘If an inter partes review petition is filed under section 311, the patent owner shall 
have the right to file a preliminary response to the petition, within a time period 
set by the Director, that sets forth reasons why no inter partes review should be 
instituted based upon the failure of the petition to meet any requirement of this 
chapter. 
-‘Sec. 314. Institution of inter partes review 
‘(a) Threshold- The Director may not authorize an inter partes review to be 
instituted unless the Director determines that the information presented in the 
petition filed under section 311 and any response filed under section 313 shows 
that there is a reasonable likelihood that the petitioner would prevail with respect 
to at least 1 of the claims challenged in the petition. 
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‘(b) Timing- The Director shall determine whether to institute an inter partes 
review under this chapter pursuant to a petition filed under section 311 within 3 
months after-- 
‘(1) receiving a preliminary response to the petition under section 313; or 
‘(2) if no such preliminary response is filed, the last date on which such 
response may be filed. 
‘(c) Notice- The Director shall notify the petitioner and patent owner, in writing, 
of the Director’s determination under subsection (a), and shall make such notice 
available to the public as soon as is practicable. Such notice shall include the date 
on which the review shall commence. 
‘(d) No Appeal- The determination by the Director whether to institute an inter 
partes review under this section shall be final and nonappealable. 
-‘Sec. 315. Relation to other proceedings or actions 
‘(a) Infringer’s Civil Action- 
‘(1) INTER PARTES REVIEW BARRED BY CIVIL ACTION- An inter 
partes review may not be instituted if, before the date on which the 
petition for such a review is filed, the petitioner or real party in interest 
filed a civil action challenging the validity of a claim of the patent. 
‘(2) STAY OF CIVIL ACTION- If the petitioner or real party in interest 
files a civil action challenging the validity of a claim of the patent on or 
after the date on which the petitioner files a petition for inter partes review 
of the patent, that civil action shall be automatically stayed until either-- 
‘(A) the patent owner moves the court to lift the stay; 
‘(B) the patent owner files a civil action or counterclaim alleging 
that the petitioner or real party in interest has infringed the patent; 
or 
‘(C) the petitioner or real party in interest moves the court to 
dismiss the civil action. 
‘(3) TREATMENT OF COUNTERCLAIM- A counterclaim challenging 
the validity of a claim of a patent does not constitute a civil action 




‘(b) Patent Owner’s Action- An inter partes review may not be instituted if the 
petition requesting the proceeding is filed more than 1 year after the date on 
which the petitioner, real party in interest, or privy of the petitioner is served with 
a complaint alleging infringement of the patent. The time limitation set forth in 
the preceding sentence shall not apply to a request for joinder under subsection 
(c). 
‘(c) Joinder- If the Director institutes an inter partes review, the Director, in his or 
her discretion, may join as a party to that inter partes review any person who 
properly files a petition under section 311 that the Director, after receiving a 
preliminary response under section 313 or the expiration of the time for filing 
such a response, determines warrants the institution of an inter partes review 
under section 314. 
‘(d) Multiple Proceedings- Notwithstanding sections 135(a), 251, and 252, and 
chapter 30, during the pendency of an inter partes review, if another proceeding or 
matter involving the patent is before the Office, the Director may determine the 
manner in which the inter partes review or other proceeding or matter may 
proceed, including providing for stay, transfer, consolidation, or termination of 
any such matter or proceeding. 
‘(e) Estoppel- 
‘(1) PROCEEDINGS BEFORE THE OFFICE- The petitioner in an inter 
partes review of a claim in a patent under this chapter that results in a final 
written decision under section 318(a), or the real party in interest or privy 
of the petitioner, may not request or maintain a proceeding before the 
Office with respect to that claim on any ground that the petitioner raised or 
reasonably could have raised during that inter partes review. 
‘(2) CIVIL ACTIONS AND OTHER PROCEEDINGS- The petitioner in 
an inter partes review of a claim in a patent under this chapter that results 
in a final written decision under section 318(a), or the real party in interest 
or privy of the petitioner, may not assert either in a civil action arising in 
whole or in part under section 1338 of title 28 or in a proceeding before 
the International Trade Commission under section 337 of the Tariff Act of 
1930 that the claim is invalid on any ground that the petitioner raised or 
reasonably could have raised during that inter partes review. 
-‘Sec. 316. Conduct of inter partes review 
‘(a) Regulations- The Director shall prescribe regulations-- 
‘(1) providing that the file of any proceeding under this chapter shall be 
made available to the public, except that any petition or document filed 
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with the intent that it be sealed shall, if accompanied by a motion to seal, 
be treated as sealed pending the outcome of the ruling on the motion; 
‘(2) setting forth the standards for the showing of sufficient grounds to 
institute a review under section 314(a); 
‘(3) establishing procedures for the submission of supplemental 
information after the petition is filed; 
‘(4) establishing and governing inter partes review under this chapter and 
the relationship of such review to other proceedings under this title; 
‘(5) setting forth standards and procedures for discovery of relevant 
evidence, including that such discovery shall be limited to-- 
‘(A) the deposition of witnesses submitting affidavits or 
declarations; and 
‘(B) what is otherwise necessary in the interest of justice; 
‘(6) prescribing sanctions for abuse of discovery, abuse of process, or any 
other improper use of the proceeding, such as to harass or to cause 
unnecessary delay or an unnecessary increase in the cost of the 
proceeding; 
‘(7) providing for protective orders governing the exchange and 
submission of confidential information; 
‘(8) providing for the filing by the patent owner of a response to the 
petition under section 313 after an inter partes review has been instituted, 
and requiring that the patent owner file with such response, through 
affidavits or declarations, any additional factual evidence and expert 
opinions on which the patent owner relies in support of the response; 
‘(9) setting forth standards and procedures for allowing the patent owner 
to move to amend the patent under subsection (d) to cancel a challenged 
claim or propose a reasonable number of substitute claims, and ensuring 
that any information submitted by the patent owner in support of any 
amendment entered under subsection (d) is made available to the public as 
part of the prosecution history of the patent; 
‘(10) providing either party with the right to an oral hearing as part of the 
proceeding; 
‘(11) requiring that the final determination in an inter partes review be 
issued not later than 1 year after the date on which the Director notices the 
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institution of a review under this chapter, except that the Director may, for 
good cause shown, extend the 1-year period by not more than 6 months, 
and may adjust the time periods in this paragraph in the case of joinder 
under section 315(c); 
‘(12) setting a time period for requesting joinder under section 315(c); and 
‘(13) providing the petitioner with at least 1 opportunity to file written 
comments within a time period established by the Director. 
‘(b) Considerations- In prescribing regulations under this section, the Director 
shall consider the effect of any such regulation on the economy, the integrity of 
the patent system, the efficient administration of the Office, and the ability of the 
Office to timely complete proceedings instituted under this chapter. 
‘(c) Patent Trial and Appeal Board- The Patent Trial and Appeal Board shall, in 
accordance with section 6, conduct each inter partes review instituted under this 
chapter. 
‘(d) Amendment of the Patent- 
‘(1) IN GENERAL- During an inter partes review instituted under this 
chapter, the patent owner may file 1 motion to amend the patent in 1 or 
more of the following ways: 
‘(A) Cancel any challenged patent claim. 
‘(B) For each challenged claim, propose a reasonable number of 
substitute claims. 
‘(2) ADDITIONAL MOTIONS- Additional motions to amend may be 
permitted upon the joint request of the petitioner and the patent owner to 
materially advance the settlement of a proceeding under section 317, or as 
permitted by regulations prescribed by the Director. 
‘(3) SCOPE OF CLAIMS- An amendment under this subsection may not 
enlarge the scope of the claims of the patent or introduce new matter. 
‘(e) Evidentiary Standards- In an inter partes review instituted under this chapter, 
the petitioner shall have the burden of proving a proposition of unpatentability by 
a preponderance of the evidence. 
-‘Sec. 317. Settlement 
‘(a) In General- An inter partes review instituted under this chapter shall be 
terminated with respect to any petitioner upon the joint request of the petitioner 
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and the patent owner, unless the Office has decided the merits of the proceeding 
before the request for termination is filed. If the inter partes review is terminated 
with respect to a petitioner under this section, no estoppel under section 315(e) 
shall attach to the petitioner, or to the real party in interest or privy of the 
petitioner, on the basis of that petitioner’s institution of that inter partes review. If 
no petitioner remains in the inter partes review, the Office may terminate the 
review or proceed to a final written decision under section 318(a). 
‘(b) Agreements in Writing- Any agreement or understanding between the patent 
owner and a petitioner, including any collateral agreements referred to in such 
agreement or understanding, made in connection with, or in contemplation of, the 
termination of an inter partes review under this section shall be in writing and a 
true copy of such agreement or understanding shall be filed in the Office before 
the termination of the inter partes review as between the parties. At the request of 
a party to the proceeding, the agreement or understanding shall be treated as 
business confidential information, shall be kept separate from the file of the 
involved patents, and shall be made available only to Federal Government 
agencies on written request, or to any person on a showing of good cause. 
-‘Sec. 318. Decision of the Board 
‘(a) Final Written Decision- If an inter partes review is instituted and not 
dismissed under this chapter, the Patent Trial and Appeal Board shall issue a final 
written decision with respect to the patentability of any patent claim challenged 
by the petitioner and any new claim added under section 316(d). 
‘(b) Certificate- If the Patent Trial and Appeal Board issues a final written 
decision under subsection (a) and the time for appeal has expired or any appeal 
has terminated, the Director shall issue and publish a certificate canceling any 
claim of the patent finally determined to be unpatentable, confirming any claim of 
the patent determined to be patentable, and incorporating in the patent by 
operation of the certificate any new or amended claim determined to be 
patentable. 
‘(c) Intervening Rights- Any proposed amended or new claim determined to be 
patentable and incorporated into a patent following an inter partes review under 
this chapter shall have the same effect as that specified in section 252 for reissued 
patents on the right of any person who made, purchased, or used within the United 
States, or imported into the United States, anything patented by such proposed 
amended or new claim, or who made substantial preparation therefor, before the 
issuance of a certificate under subsection (b). 
‘(d) Data on Length of Review- The Office shall make available to the public data 
describing the length of time between the institution of, and the issuance of a final 
written decision under subsection (a) for, each inter partes review. 
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-‘Sec. 319. Appeal 
‘A party dissatisfied with the final written decision of the Patent Trial and Appeal 
Board under section 318(a) may appeal the decision pursuant to sections 141 
through 144. Any party to the inter partes review shall have the right to be a party 
to the appeal.’. 
(b) Conforming Amendment- The table of chapters for part III of title 35, United 
States Code, is amended by striking the item relating to chapter 31 and inserting 
the following: 
311’. 
(c) Regulations and Effective Date- 
(1) REGULATIONS- The Director shall, not later than the date that is 1 year after 
the date of the enactment of this Act, issue regulations to carry out chapter 31 of 
title 35, United States Code, as amended by subsection (a) of this section. 
(2) APPLICABILITY- 
(A) IN GENERAL- The amendments made by subsection (a) shall take 
effect upon the expiration of the 1-year period beginning on the date of the 
enactment of this Act and shall apply to any patent issued before, on, or 
after that effective date. 
(B) GRADUATED IMPLEMENTATION- The Director may impose a 
limit on the number of inter partes reviews that may be instituted under 
chapter 31 of title 35, United States Code, during each of the first 4 1-year 
periods in which the amendments made by subsection (a) are in effect, if 
such number in each year equals or exceeds the number of inter partes 
reexaminations that are ordered under chapter 31 of title 35, United States 
Code, in the last fiscal year ending before the effective date of the 
amendments made by subsection (a). 
(3) TRANSITION- 
(A) IN GENERAL- Chapter 31 of title 35, United States Code, is 
amended-- 
(i) in section 312-- 
(I) in subsection (a)-- 
(aa) in the first sentence, by striking ‘a substantial new question of patentability affecting any 
claim of the patent concerned is raised by the request,’ and inserting ‘the information presented 
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in the request shows that there is a reasonable likelihood that the requester would prevail with 
respect to at least 1 of the claims challenged in the request,’; and 
(bb) in the second sentence, by striking ‘The existence of a substantial new question of 
patentability’ and inserting ‘A showing that there is a reasonable likelihood that the requester 
would prevail with respect to at least 1 of the claims challenged in the request’; and 
(II) in subsection (c), in the second sentence, by striking 
‘no substantial new question of patentability has been 
raised,’ and inserting ‘the showing required by subsection 
(a) has not been made,’; and 
(ii) in section 313, by striking ‘a substantial new question of 
patentability affecting a claim of the patent is raised’ and inserting 
‘it has been shown that there is a reasonable likelihood that the 
requester would prevail with respect to at least 1 of the claims 
challenged in the request’. 
(B) APPLICATION- The amendments made by this paragraph-- 
(i) shall take effect on the date of the enactment of this Act; and 
(ii) shall apply to requests for inter partes reexamination that are 
filed on or after such date of enactment, but before the effective 
date set forth in paragraph (2)(A) of this subsection. 
(C) CONTINUED APPLICABILITY OF PRIOR PROVISIONS- The 
provisions of chapter 31 of title 35, United States Code, as amended by 
this paragraph, shall continue to apply to requests for inter partes 
reexamination that are filed before the effective date set forth in paragraph 
(2)(A) as if subsection (a) had not been enacted. 
(d) Post-Grant Review- Part III of title 35, United States Code, is amended by adding at 
the end the following: 
‘CHAPTER 32--POST-GRANT REVIEW 
‘Sec. 
‘321. Post-grant review. 
‘322. Petitions. 
‘323. Preliminary response to petition. 
‘324. Institution of post-grant review. 
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‘325. Relation to other proceedings or actions. 
‘326. Conduct of post-grant review. 
‘327. Settlement. 
‘328. Decision of the Board. 
‘329. Appeal. 
-‘Sec. 321. Post-grant review 
‘(a) In General- Subject to the provisions of this chapter, a person who is not the 
owner of a patent may file with the Office a petition to institute a post-grant 
review of the patent. The Director shall establish, by regulation, fees to be paid by 
the person requesting the review, in such amounts as the Director determines to be 
reasonable, considering the aggregate costs of the post-grant review. 
‘(b) Scope- A petitioner in a post-grant review may request to cancel as 
unpatentable 1 or more claims of a patent on any ground that could be raised 
under paragraph (2) or (3) of section 282(b) (relating to invalidity of the patent or 
any claim). 
‘(c) Filing Deadline- A petition for a post-grant review may only be filed not later 
than the date that is 9 months after the date of the grant of the patent or of the 
issuance of a reissue patent (as the case may be). 
-‘Sec. 322. Petitions 
‘(a) Requirements of Petition- A petition filed under section 321 may be 
considered only if-- 
‘(1) the petition is accompanied by payment of the fee established by the 
Director under section 321; 
‘(2) the petition identifies all real parties in interest; 
‘(3) the petition identifies, in writing and with particularity, each claim 
challenged, the grounds on which the challenge to each claim is based, and 
the evidence that supports the grounds for the challenge to each claim, 
including-- 
‘(A) copies of patents and printed publications that the petitioner 
relies upon in support of the petition; and 
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‘(B) affidavits or declarations of supporting evidence and opinions, 
if the petitioner relies on other factual evidence or on expert 
opinions; 
‘(4) the petition provides such other information as the Director may 
require by regulation; and 
‘(5) the petitioner provides copies of any of the documents required under 
paragraphs (2), (3), and (4) to the patent owner or, if applicable, the 
designated representative of the patent owner. 
‘(b) Public Availability- As soon as practicable after the receipt of a petition 
under section 321, the Director shall make the petition available to the public. 
-‘Sec. 323. Preliminary response to petition 
‘If a post-grant review petition is filed under section 321, the patent owner shall 
have the right to file a preliminary response to the petition, within a time period 
set by the Director, that sets forth reasons why no post-grant review should be 
instituted based upon the failure of the petition to meet any requirement of this 
chapter. 
-‘Sec. 324. Institution of post-grant review 
‘(a) Threshold- The Director may not authorize a post-grant review to be 
instituted unless the Director determines that the information presented in the 
petition filed under section 321, if such information is not rebutted, would 
demonstrate that it is more likely than not that at least 1 of the claims challenged 
in the petition is unpatentable. 
‘(b) Additional Grounds- The determination required under subsection (a) may 
also be satisfied by a showing that the petition raises a novel or unsettled legal 
question that is important to other patents or patent applications. 
‘(c) Timing- The Director shall determine whether to institute a post-grant review 
under this chapter pursuant to a petition filed under section 321 within 3 months 
after-- 
‘(1) receiving a preliminary response to the petition under section 323; or 
‘(2) if no such preliminary response is filed, the last date on which such 
response may be filed. 
‘(d) Notice- The Director shall notify the petitioner and patent owner, in writing, 
of the Director’s determination under subsection (a) or (b), and shall make such 
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notice available to the public as soon as is practicable. Such notice shall include 
the date on which the review shall commence. 
‘(e) No Appeal- The determination by the Director whether to institute a post-
grant review under this section shall be final and nonappealable. 
-‘Sec. 325. Relation to other proceedings or actions 
‘(a) Infringer’s Civil Action- 
‘(1) POST-GRANT REVIEW BARRED BY CIVIL ACTION- A post-
grant review may not be instituted under this chapter if, before the date on 
which the petition for such a review is filed, the petitioner or real party in 
interest filed a civil action challenging the validity of a claim of the patent. 
‘(2) STAY OF CIVIL ACTION- If the petitioner or real party in interest 
files a civil action challenging the validity of a claim of the patent on or 
after the date on which the petitioner files a petition for post-grant review 
of the patent, that civil action shall be automatically stayed until either-- 
‘(A) the patent owner moves the court to lift the stay; 
‘(B) the patent owner files a civil action or counterclaim alleging 
that the petitioner or real party in interest has infringed the patent; 
or 
‘(C) the petitioner or real party in interest moves the court to 
dismiss the civil action. 
‘(3) TREATMENT OF COUNTERCLAIM- A counterclaim challenging 
the validity of a claim of a patent does not constitute a civil action 
challenging the validity of a claim of a patent for purposes of this 
subsection. 
‘(b) Preliminary Injunctions- If a civil action alleging infringement of a patent is 
filed within 3 months after the date on which the patent is granted, the court may 
not stay its consideration of the patent owner’s motion for a preliminary 
injunction against infringement of the patent on the basis that a petition for post-
grant review has been filed under this chapter or that such a post-grant review has 
been instituted under this chapter. 
‘(c) Joinder- If more than 1 petition for a post-grant review under this chapter is 
properly filed against the same patent and the Director determines that more than 
1 of these petitions warrants the institution of a post-grant review under section 
324, the Director may consolidate such reviews into a single post-grant review. 
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‘(d) Multiple Proceedings- Notwithstanding sections 135(a), 251, and 252, and 
chapter 30, during the pendency of any post-grant review under this chapter, if 
another proceeding or matter involving the patent is before the Office, the 
Director may determine the manner in which the post-grant review or other 
proceeding or matter may proceed, including providing for the stay, transfer, 
consolidation, or termination of any such matter or proceeding. In determining 
whether to institute or order a proceeding under this chapter, chapter 30, or 
chapter 31, the Director may take into account whether, and reject the petition or 
request because, the same or substantially the same prior art or arguments 
previously were presented to the Office. 
‘(e) Estoppel- 
‘(1) PROCEEDINGS BEFORE THE OFFICE- The petitioner in a post-
grant review of a claim in a patent under this chapter that results in a final 
written decision under section 328(a), or the real party in interest or privy 
of the petitioner, may not request or maintain a proceeding before the 
Office with respect to that claim on any ground that the petitioner raised or 
reasonably could have raised during that post-grant review. 
‘(2) CIVIL ACTIONS AND OTHER PROCEEDINGS- The petitioner in 
a post-grant review of a claim in a patent under this chapter that results in 
a final written decision under section 328(a), or the real party in interest or 
privy of the petitioner, may not assert either in a civil action arising in 
whole or in part under section 1338 of title 28 or in a proceeding before 
the International Trade Commission under section 337 of the Tariff Act of 
1930 that the claim is invalid on any ground that the petitioner raised or 
reasonably could have raised during that post-grant review. 
‘(f) Reissue Patents- A post-grant review may not be instituted under this 
chapter if the petition requests cancellation of a claim in a reissue patent that 
is identical to or narrower than a claim in the original patent from which the 
reissue patent was issued, and the time limitations in section 321(c) would 
bar filing a petition for a post-grant review for such original patent. 
[Analysis: Post grant review could be used to challenge reissued claims, even if 
they were not broadened or otherwise amended during the reissue proceeding.  
Bottom line: under H.R. 6621, reissue resets the 9-month clock for post grant 
review for all claims.] 
-‘Sec. 326. Conduct of post-grant review 
‘(a) Regulations- The Director shall prescribe regulations-- 
‘(1) providing that the file of any proceeding under this chapter shall be 
made available to the public, except that any petition or document filed 
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with the intent that it be sealed shall, if accompanied by a motion to seal, 
be treated as sealed pending the outcome of the ruling on the motion; 
‘(2) setting forth the standards for the showing of sufficient grounds to 
institute a review under subsections (a) and (b) of section 324; 
‘(3) establishing procedures for the submission of supplemental 
information after the petition is filed; 
‘(4) establishing and governing a post-grant review under this chapter and 
the relationship of such review to other proceedings under this title; 
‘(5) setting forth standards and procedures for discovery of relevant 
evidence, including that such discovery shall be limited to evidence 
directly related to factual assertions advanced by either party in the 
proceeding; 
‘(6) prescribing sanctions for abuse of discovery, abuse of process, or any 
other improper use of the proceeding, such as to harass or to cause 
unnecessary delay or an unnecessary increase in the cost of the 
proceeding; 
‘(7) providing for protective orders governing the exchange and 
submission of confidential information; 
‘(8) providing for the filing by the patent owner of a response to the 
petition under section 323 after a post-grant review has been instituted, 
and requiring that the patent owner file with such response, through 
affidavits or declarations, any additional factual evidence and expert 
opinions on which the patent owner relies in support of the response; 
‘(9) setting forth standards and procedures for allowing the patent owner 
to move to amend the patent under subsection (d) to cancel a challenged 
claim or propose a reasonable number of substitute claims, and ensuring 
that any information submitted by the patent owner in support of any 
amendment entered under subsection (d) is made available to the public as 
part of the prosecution history of the patent; 
‘(10) providing either party with the right to an oral hearing as part of the 
proceeding; 
‘(11) requiring that the final determination in any post-grant review be 
issued not later than 1 year after the date on which the Director notices the 
institution of a proceeding under this chapter, except that the Director 
may, for good cause shown, extend the 1-year period by not more than 6 
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months, and may adjust the time periods in this paragraph in the case of 
joinder under section 325(c); and 
‘(12) providing the petitioner with at least 1 opportunity to file written 
comments within a time period established by the Director. 
‘(b) Considerations- In prescribing regulations under this section, the Director 
shall consider the effect of any such regulation on the economy, the integrity of 
the patent system, the efficient administration of the Office, and the ability of the 
Office to timely complete proceedings instituted under this chapter. 
‘(c) Patent Trial and Appeal Board- The Patent Trial and Appeal Board shall, in 
accordance with section 6, conduct each post-grant review instituted under this 
chapter. 
‘(d) Amendment of the Patent- 
‘(1) IN GENERAL- During a post-grant review instituted under this 
chapter, the patent owner may file 1 motion to amend the patent in 1 or 
more of the following ways: 
‘(A) Cancel any challenged patent claim. 
‘(B) For each challenged claim, propose a reasonable number of 
substitute claims. 
‘(2) ADDITIONAL MOTIONS- Additional motions to amend may be 
permitted upon the joint request of the petitioner and the patent owner to 
materially advance the settlement of a proceeding under section 327, or 
upon the request of the patent owner for good cause shown. 
‘(3) SCOPE OF CLAIMS- An amendment under this subsection may not 
enlarge the scope of the claims of the patent or introduce new matter. 
‘(e) Evidentiary Standards- In a post-grant review instituted under this chapter, 
the petitioner shall have the burden of proving a proposition of unpatentability by 
a preponderance of the evidence. 
-‘Sec. 327. Settlement 
‘(a) In General- A post-grant review instituted under this chapter shall be 
terminated with respect to any petitioner upon the joint request of the petitioner 
and the patent owner, unless the Office has decided the merits of the proceeding 
before the request for termination is filed. If the post-grant review is terminated 
with respect to a petitioner under this section, no estoppel under section 325(e) 
shall attach to the petitioner, or to the real party in interest or privy of the 
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petitioner, on the basis of that petitioner’s institution of that post-grant review. If 
no petitioner remains in the post-grant review, the Office may terminate the post-
grant review or proceed to a final written decision under section 328(a). 
‘(b) Agreements in Writing- Any agreement or understanding between the patent 
owner and a petitioner, including any collateral agreements referred to in such 
agreement or understanding, made in connection with, or in contemplation of, the 
termination of a post-grant review under this section shall be in writing, and a true 
copy of such agreement or understanding shall be filed in the Office before the 
termination of the post-grant review as between the parties. At the request of a 
party to the proceeding, the agreement or understanding shall be treated as 
business confidential information, shall be kept separate from the file of the 
involved patents, and shall be made available only to Federal Government 
agencies on written request, or to any person on a showing of good cause. 
-‘Sec. 328. Decision of the Board 
‘(a) Final Written Decision- If a post-grant review is instituted and not dismissed 
under this chapter, the Patent Trial and Appeal Board shall issue a final written 
decision with respect to the patentability of any patent claim challenged by the 
petitioner and any new claim added under section 326(d). 
‘(b) Certificate- If the Patent Trial and Appeal Board issues a final written 
decision under subsection (a) and the time for appeal has expired or any appeal 
has terminated, the Director shall issue and publish a certificate canceling any 
claim of the patent finally determined to be unpatentable, confirming any claim of 
the patent determined to be patentable, and incorporating in the patent by 
operation of the certificate any new or amended claim determined to be 
patentable. 
‘(c) Intervening Rights- Any proposed amended or new claim determined to be 
patentable and incorporated into a patent following a post-grant review under this 
chapter shall have the same effect as that specified in section 252 of this title for 
reissued patents on the right of any person who made, purchased, or used within 
the United States, or imported into the United States, anything patented by such 
proposed amended or new claim, or who made substantial preparation therefor, 
before the issuance of a certificate under subsection (b). 
‘(d) Data on Length of Review- The Office shall make available to the public data 
describing the length of time between the institution of, and the issuance of a final 
written decision under subsection (a) for, each post-grant review. 
-‘Sec. 329. Appeal 
‘A party dissatisfied with the final written decision of the Patent Trial and Appeal 
Board under section 328(a) may appeal the decision pursuant to sections 141 
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through 144. Any party to the post-grant review shall have the right to be a party 
to the appeal.’. 
(e) Conforming Amendment- The table of chapters for part III of title 35, United 
States Code, is amended by adding at the end the following: 
321’. 
(f) Regulations and Effective Date- 
(1) REGULATIONS- The Director shall, not later than the date that is 1 year after 
the date of the enactment of this Act, issue regulations to carry out chapter 32 of 
title 35, United States Code, as added by subsection (d) of this section. 
(2) APPLICABILITY- 
(A) IN GENERAL- The amendments made by subsection (d) shall take 
effect upon the expiration of the 1-year period beginning on the date of the 
enactment of this Act and, except as provided in section 18 and in 
paragraph (3), shall apply only to patents described in section 3(n)(1). 
(B) LIMITATION- The Director may impose a limit on the number of 
post-grant reviews that may be instituted under chapter 32 of title 35, 
United States Code, during each of the first 4 1-year periods in which the 
amendments made by subsection (d) are in effect. 
(3) PENDING INTERFERENCES- 
(A) PROCEDURES IN GENERAL- The Director shall determine, and 
include in the regulations issued under paragraph (1), the procedures under 
which an interference commenced before the effective date set forth in 
paragraph (2)(A) is to proceed, including whether such interference-- 
(i) is to be dismissed without prejudice to the filing of a petition for 
a post-grant review under chapter 32 of title 35, United States 
Code; or 
(ii) is to proceed as if this Act had not been enacted. 
(B) PROCEEDINGS BY PATENT TRIAL AND APPEAL BOARD- For 
purposes of an interference that is commenced before the effective date set 
forth in paragraph (2)(A), the Director may deem the Patent Trial and 
Appeal Board to be the Board of Patent Appeals and Interferences, and 
may allow the Patent Trial and Appeal Board to conduct any further 
proceedings in that interference. 
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(C) APPEALS- The authorization to appeal or have remedy from 
derivation proceedings in sections 141(d) and 146 of title 35, United States 
Code, as amended by this Act, and the jurisdiction to entertain appeals 
from derivation proceedings in section 1295(a)(4)(A) of title 28, United 
States Code, as amended by this Act, shall be deemed to extend to any 
final decision in an interference that is commenced before the effective 
date set forth in paragraph (2)(A) of this subsection and that is not 
dismissed pursuant to this paragraph. 
(g) Citation of Prior Art and Written Statements- 
(1) IN GENERAL- Section 301 of title 35, United States Code, is amended to 
read as follows: 
-‘Sec. 301. Citation of prior art and written statements 
‘(a) In General- Any person at any time may cite to the Office in writing-- 
‘(1) prior art consisting of patents or printed publications which that 
person believes to have a bearing on the patentability of any claim of a 
particular patent; or 
‘(2) statements of the patent owner filed in a proceeding before a Federal 
court or the Office in which the patent owner took a position on the scope 
of any claim of a particular patent. 
‘(b) Official File- If the person citing prior art or written statements pursuant to 
subsection (a) explains in writing the pertinence and manner of applying the prior 
art or written statements to at least 1 claim of the patent, the citation of the prior 
art or written statements and the explanation thereof shall become a part of the 
official file of the patent. 
‘(c) Additional Information- A party that submits a written statement pursuant to 
subsection (a)(2) shall include any other documents, pleadings, or evidence from 
the proceeding in which the statement was filed that addresses the written 
statement. 
‘(d) Limitations- A written statement submitted pursuant to subsection (a)(2), and 
additional information submitted pursuant to subsection (c), shall not be 
considered by the Office for any purpose other than to determine the proper 
meaning of a patent claim in a proceeding that is ordered or instituted pursuant to 
section 304, 314, or 324. If any such written statement or additional information is 
subject to an applicable protective order, such statement or information shall be 
redacted to exclude information that is subject to that order. 
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‘(e) Confidentiality- Upon the written request of the person citing prior art or 
written statements pursuant to subsection (a), that person’s identity shall be 
excluded from the patent file and kept confidential.’. 
(2) CONFORMING AMENDMENT- The item relating to section 301 in 
the table of sections for chapter 30 of title 35, United States Code, is 
amended to read as follows: 
‘301. Citation of prior art and written statements.’. 
(3) EFFECTIVE DATE- The amendments made by this subsection shall 
take effect upon the expiration of the 1-year period beginning on the date 
of the enactment of this Act and shall apply to any patent issued before, 
on, or after that effective date. 
(h) Reexamination- 
(1) DETERMINATION BY DIRECTOR- 
(A) IN GENERAL- Section 303(a) of title 35, United States Code, 
is amended by striking ‘section 301 of this title’ and inserting 
‘section 301 or 302’. 
(B) EFFECTIVE DATE- The amendment made by this paragraph 
shall take effect upon the expiration of the 1-year period beginning 
on the date of the enactment of this Act and shall apply to any 
patent issued before, on, or after that effective date. 
(2) APPEAL- 
(A) IN GENERAL- Section 306 of title 35, United States Code, is 
amended by striking ‘145’ and inserting ‘144’. 
(B) EFFECTIVE DATE- The amendment made by this paragraph 
shall take effect on the date of the enactment of this Act and shall 
apply to any appeal of a reexamination before the Board of Patent 
Appeals and Interferences or the Patent Trial and Appeal Board 
that is pending on, or brought on or after, the date of the enactment 
of this Act. 
SEC. 7. PATENT TRIAL AND APPEAL BOARD. 
(a) Composition and Duties- 




-‘Sec. 6. Patent Trial and Appeal Board 
‘(a) In General- There shall be in the Office a Patent Trial and Appeal Board. The 
Director, the Deputy Director, the Commissioner for Patents, the Commissioner 
for Trademarks, and the administrative patent judges shall constitute the Patent 
Trial and Appeal Board. The administrative patent judges shall be persons of 
competent legal knowledge and scientific ability who are appointed by the 
Secretary, in consultation with the Director. Any reference in any Federal law, 
Executive order, rule, regulation, or delegation of authority, or any document of 
or pertaining to the Board of Patent Appeals and Interferences is deemed to refer 
to the Patent Trial and Appeal Board. 
‘(b) Duties- The Patent Trial and Appeal Board shall-- 
‘(1) on written appeal of an applicant, review adverse decisions of 
examiners upon applications for patents pursuant to section 134(a); 
‘(2) review appeals of reexaminations pursuant to section 134(b); 
‘(3) conduct derivation proceedings pursuant to section 135; and 
‘(4) conduct inter partes reviews and post-grant reviews pursuant to 
chapters 31 and 32. 
‘(c) 3-Member Panels- Each appeal, derivation proceeding, post-grant review, and 
inter partes review shall be heard by at least 3 members of the Patent Trial and 
Appeal Board, who shall be designated by the Director. Only the Patent Trial and 
Appeal Board may grant rehearings. 
‘(d) Treatment of Prior Appointments- The Secretary of Commerce may, in the 
Secretary’s discretion, deem the appointment of an administrative patent judge 
who, before the date of the enactment of this subsection, held office pursuant to 
an appointment by the Director to take effect on the date on which the Director 
initially appointed the administrative patent judge. It shall be a defense to a 
challenge to the appointment of an administrative patent judge on the basis of the 
judge’s having been originally appointed by the Director that the administrative 
patent judge so appointed was acting as a de facto officer.’. 
(2) CONFORMING AMENDMENT- The item relating to section 6 in the 
table of sections for chapter 1 of title 35, United States Code, is amended 
to read as follows: 
‘6. Patent Trial and Appeal Board.’. 




(1) in subsection (b), by striking ‘any reexamination proceeding’ and 
inserting ‘a reexamination’; and 
(2) by striking subsection (c). 
(c) Circuit Appeals- 
(1) IN GENERAL- Section 141 of title 35, United States Code, is 
amended to read as follows: 
-‘Sec. 141. Appeal to Court of Appeals for the Federal Circuit 
‘(a) Examinations- An applicant who is dissatisfied with the final decision in an 
appeal to the Patent Trial and Appeal Board under section 134(a) may appeal the 
Board’s decision to the United States Court of Appeals for the Federal Circuit. By 
filing such an appeal, the applicant waives his or her right to proceed under 
section 145. 
‘(b) Reexaminations- A patent owner who is dissatisfied with the final decision in 
an appeal of a reexamination to the Patent Trial and Appeal Board under section 
134(b) may appeal the Board’s decision only to the United States Court of 
Appeals for the Federal Circuit. 
‘(c) Post-Grant and Inter Partes Reviews- A party to an inter partes review or a 
post-grant review who is dissatisfied with the final written decision of the Patent 
Trial and Appeal Board under section 318(a) or 328(a) (as the case may be) may 
appeal the Board’s decision only to the United States Court of Appeals for the 
Federal Circuit. 
‘(d) Derivation Proceedings- A party to a derivation proceeding who is 
dissatisfied with the final decision of the Patent Trial and Appeal Board in the 
proceeding may appeal the decision to the United States Court of Appeals for the 
Federal Circuit, but such appeal shall be dismissed if any adverse party to such 
derivation proceeding, within 20 days after the appellant has filed notice of appeal 
in accordance with section 142, files notice with the Director that the party elects 
to have all further proceedings conducted as provided in section 146. If the 
appellant does not, within 30 days after the filing of such notice by the adverse 
party, file a civil action under section 146, the Board’s decision shall govern the 
further proceedings in the case.’. 
(2) JURISDICTION- Section 1295(a)(4)(A) of title 28, United States 
Code, is amended to read as follows: 
‘(A) the Patent Trial and Appeal Board of the United States Patent 
and Trademark Office with respect to a patent application, 
derivation proceeding, reexamination, post-grant review, or inter 
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partes review under title 35, at the instance of a party who 
exercised that party’s right to participate in the applicable 
proceeding before or appeal to the Board, except that an applicant 
or a party to a derivation proceeding may also have remedy by 
civil action pursuant to section 145 or 146 of title 35; an appeal 
under this subparagraph of a decision of the Board with respect to 
an application or derivation proceeding shall waive the right of 
such applicant or party to proceed under section 145 or 146 of title 
35;’. 
(3) PROCEEDINGS ON APPEAL- Section 143 of title 35, United States 
Code, is amended-- 
(A) by striking the third sentence and inserting the following: ‘In 
an ex parte case, the Director shall submit to the court in writing 
the grounds for the decision of the Patent and Trademark Office, 
addressing all of the issues raised in the appeal. The Director shall 
have the right to intervene in an appeal from a decision entered by 
the Patent Trial and Appeal Board in a derivation proceeding under 
section 135 or in an inter partes or post-grant review under chapter 
31 or 32.’; and 
(B) by striking the last sentence. 
(d) Conforming Amendments- 
(1) ATOMIC ENERGY ACT OF 1954- Section 152 of the Atomic Energy 
Act of 1954 (42 U.S.C. 2182) is amended in the third undesignated 
paragraph-- 
(A) by striking ‘Board of Patent Appeals and Interferences’ each 
place it appears and inserting ‘Patent Trial and Appeal Board’; and 
(B) by inserting ‘and derivation’ after ‘established for 
interference’. 
(2) TITLE 51- Section 20135 of title 51, United States Code, is amended-- 
(A) in subsections (e) and (f), by striking ‘Board of Patent Appeals 
and Interferences’ each place it appears and inserting ‘Patent Trial 
and Appeal Board’; and 
(B) in subsection (e), by inserting ‘and derivation’ after 
‘established for interference’. 
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(e) Effective Date- The amendments made by this section shall take effect upon 
the expiration of the 1-year period beginning on the date of the enactment of this 
Act and shall apply to proceedings commenced on or after that effective date, 
except that-- 
(1) the extension of jurisdiction to the United States Court of Appeals for 
the Federal Circuit to entertain appeals of decisions of the Patent Trial and 
Appeal Board in reexaminations under the amendment made by 
subsection (c)(2) shall be deemed to take effect on the date of the 
enactment of this Act and shall extend to any decision of the Board of 
Patent Appeals and Interferences with respect to a reexamination that is 
entered before, on, or after the date of the enactment of this Act; 
(2) the provisions of sections 6, 134, and 141 of title 35, United States 
Code, as in effect on the day before the effective date of the amendments 
made by this section shall continue to apply to inter partes reexaminations 
that are requested under section 311 of such title before such effective 
date; 
(3) the Patent Trial and Appeal Board may be deemed to be the Board of 
Patent Appeals and Interferences for purposes of appeals of inter partes 
reexaminations that are requested under section 311 of title 35, United 
States Code, before the effective date of the amendments made by this 
section; and 
(4) the Director’s right under the fourth sentence of section 143 of title 35, 
United States Code, as amended by subsection (c)(3) of this section, to 
intervene in an appeal from a decision entered by the Patent Trial and 
Appeal Board shall be deemed to extend to inter partes reexaminations 
that are requested under section 311 of such title before the effective date 
of the amendments made by this section. 
SEC. 8. PREISSUANCE SUBMISSIONS BY THIRD PARTIES. 
(a) In General- Section 122 of title 35, United States Code, is amended by adding at the 
end the following: 
‘(e) Preissuance Submissions by Third Parties- 
‘(1) IN GENERAL- Any third party may submit for consideration and 
inclusion in the record of a patent application, any patent, published patent 
application, or other printed publication of potential relevance to the 
examination of the application, if such submission is made in writing 
before the earlier of-- 
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‘(A) the date a notice of allowance under section 151 is given or 
mailed in the application for patent; or 
‘(B) the later of-- 
‘(i) 6 months after the date on which the application for 
patent is first published under section 122 by the Office, or 
‘(ii) the date of the first rejection under section 132 of any 
claim by the examiner during the examination of the 
application for patent. 
‘(2) OTHER REQUIREMENTS- Any submission under paragraph (1) 
shall-- 
‘(A) set forth a concise description of the asserted relevance of 
each submitted document; 
‘(B) be accompanied by such fee as the Director may prescribe; 
and 
‘(C) include a statement by the person making such submission 
affirming that the submission was made in compliance with this 
section.’. 
(b) Effective Date- The amendments made by this section shall take effect upon the 
expiration of the 1-year period beginning on the date of the enactment of this Act and 
shall apply to any patent application filed before, on, or after that effective date. 
SEC. 9. VENUE. 
(a) Technical Amendments Relating to Venue- Sections 32, 145, 146, 154(b)(4)(A), and 
293 of title 35, United States Code, and section 21(b)(4) of the Trademark Act of 1946 
(15 U.S.C. 1071(b)(4)), are each amended by striking ‘United States District Court for 
the District of Columbia’ each place that term appears and inserting ‘United States 
District Court for the Eastern District of Virginia’. 
(b) Effective Date- The amendments made by this section shall take effect on the date of 
the enactment of this Act and shall apply to any civil action commenced on or after that 
date. 
SEC. 10. FEE SETTING AUTHORITY. 
(a) Fee Setting- 
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(1) IN GENERAL- The Director may set or adjust by rule any fee established, 
authorized, or charged under title 35, United States Code, or the Trademark Act of 
1946 (15 U.S.C. 1051 et seq.), for any services performed by or materials 
furnished by, the Office, subject to paragraph (2). 
(2) FEES TO RECOVER COSTS- Fees may be set or adjusted under paragraph 
(1) only to recover the aggregate estimated costs to the Office for processing, 
activities, services, and materials relating to patents (in the case of patent fees) 
and trademarks (in the case of trademark fees), including administrative costs of 
the Office with respect to such patent or trademark fees (as the case may be). 
(b) Small and Micro Entities- The fees set or adjusted under subsection (a) for filing, 
searching, examining, issuing, appealing, and maintaining patent applications and patents 
shall be reduced by 50 percent with respect to the application of such fees to any small 
entity that qualifies for reduced fees under section 41(h)(1) of title 35, United States 
Code, and shall be reduced by 75 percent with respect to the application of such fees to 
any micro entity as defined in section 123 of that title (as added by subsection (g) of this 
section). 
(c) Reduction of Fees in Certain Fiscal Years- In each fiscal year, the Director-- 
(1) shall consult with the Patent Public Advisory Committee and the Trademark 
Public Advisory Committee on the advisability of reducing any fees described in 
subsection (a); and 
(2) after the consultation required under paragraph (1), may reduce such fees. 
(d) Role of the Public Advisory Committee- The Director shall-- 
(1) not less than 45 days before publishing any proposed fee under subsection (a) 
in the Federal Register, submit the proposed fee to the Patent Public Advisory 
Committee or the Trademark Public Advisory Committee, or both, as appropriate; 
(2)(A) provide the relevant advisory committee described in paragraph (1) a 30-
day period following the submission of any proposed fee, in which to deliberate, 
consider, and comment on such proposal; 
(B) require that, during that 30-day period, the relevant advisory committee hold a 
public hearing relating to such proposal; and 
(C) assist the relevant advisory committee in carrying out that public hearing, 
including by offering the use of the resources of the Office to notify and promote 
the hearing to the public and interested stakeholders; 
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(3) require the relevant advisory committee to make available to the public a 
written report setting forth in detail the comments, advice, and recommendations 
of the committee regarding the proposed fee; and 
(4) consider and analyze any comments, advice, or recommendations received 
from the relevant advisory committee before setting or adjusting (as the case may 
be) the fee. 
(e) Publication in the Federal Register- 
(1) PUBLICATION AND RATIONALE- The Director shall-- 
(A) publish any proposed fee change under this section in the Federal 
Register; 
(B) include, in such publication, the specific rationale and purpose for the 
proposal, including the possible expectations or benefits resulting from the 
proposed change; and 
(C) notify, through the Chair and Ranking Member of the Committees on 
the Judiciary of the Senate and the House of Representatives, the Congress 
of the proposed change not later than the date on which the proposed 
change is published under subparagraph (A). 
(2) PUBLIC COMMENT PERIOD- The Director shall, in the publication under 
paragraph (1), provide the public a period of not less than 45 days in which to 
submit comments on the proposed change in fees. 
(3) PUBLICATION OF FINAL RULE- The final rule setting or adjusting a fee 
under this section shall be published in the Federal Register and in the Official 
Gazette of the Patent and Trademark Office. 
(4) CONGRESSIONAL COMMENT PERIOD- A fee set or adjusted under 
subsection (a) may not become effective-- 
(A) before the end of the 45-day period beginning on the day after the date 
on which the Director publishes the final rule adjusting or setting the fee 
under paragraph (3); or 
(B) if a law is enacted disapproving such fee. 
(5) RULE OF CONSTRUCTION- Rules prescribed under this section shall not 
diminish-- 
(A) the rights of an applicant for a patent under title 35, United States 
Code, or for a mark under the Trademark Act of 1946; or 
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(B) any rights under a ratified treaty. 
(f) Retention of Authority- The Director retains the authority under subsection (a) to set 
or adjust fees only during such period as the Patent and Trademark Office remains an 
agency within the Department of Commerce. 
(g) Micro Entity Defined- 
(1) IN GENERAL- Chapter 11 of title 35, United States Code, is amended by 
adding at the end the following new section: 
-‘Sec. 123. Micro entity defined 
‘(a) In General- For purposes of this titleof this title, the term ‘micro entity’ 
means an applicant who makes a certification that the applicant— 
[Analysis: Apparently, correction of a non-existent typo.] 
‘(1) qualifies as a small entity, as defined in regulations issued by the 
Director; 
‘(2) has not been named as an inventor on more than 4 previously filed 
patent applications, other than applications filed in another country, 
provisional applications under section 111(b), or international applications 
filed under the treaty defined in section 351(a) for which the basic national 
fee under section 41(a) was not paid; 
‘(3) did not, in the calendar year preceding the calendar year in which the 
applicable fee is being paid, have a gross income, as defined in section 
61(a) of the Internal Revenue Code of 1986, exceeding 3 times the median 
household income for that preceding calendar year, as most recently 
reported by the Bureau of the Census; and 
‘(4) has not assigned, granted, or conveyed, and is not under an obligation 
by contract or law to assign, grant, or convey, a license or other ownership 
interest in the application concerned to an entity that, in the calendar year 
preceding the calendar year in which the applicable fee is being paid, had 
a gross income, as defined in section 61(a) of the Internal Revenue Code 
of 1986, exceeding 3 times the median household income for that 
preceding calendar year, as most recently reported by the Bureau of the 
Census. 
‘(b) Applications Resulting From Prior Employment- An applicant is not 
considered to be named on a previously filed application for purposes of 
subsection (a)(2) if the applicant has assigned, or is under an obligation by 
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contract or law to assign, all ownership rights in the application as the result of the 
applicant’s previous employment. 
‘(c) Foreign Currency Exchange Rate- If an applicant’s or entity’s gross income 
in the preceding calendar year is not in United States dollars, the average currency 
exchange rate, as reported by the Internal Revenue Service, during that calendar 
year shall be used to determine whether the applicant’s or entity’s gross income 
exceeds the threshold specified in paragraphs (3) or (4) of subsection (a). 
‘(d) Institutions of Higher Education- For purposes of this section, a micro entity 
shall include an applicant who certifies that-- 
‘(1) the applicant’s employer, from which the applicant obtains the 
majority of the applicant’s income, is an institution of higher education as 
defined in section 101(a) of the Higher Education Act of 1965 (20 U.S.C. 
1001(a)); or 
‘(2) the applicant has assigned, granted, conveyed, or is under an 
obligation by contract or law, to assign, grant, or convey, a license or other 
ownership interest in the particular applications to such an institution of 
higher education. 
‘(e) Director’s Authority- In addition to the limits imposed by this section, the 
Director may, in the Director’s discretion, impose income limits, annual filing 
limits, or other limits on who may qualify as a micro entity pursuant to this 
section if the Director determines that such additional limits are reasonably 
necessary to avoid an undue impact on other patent applicants or owners or are 
otherwise reasonably necessary and appropriate. At least 3 months before any 
limits proposed to be imposed pursuant to this subsection take effect, the Director 
shall inform the Committee on the Judiciary of the House of Representatives and 
the Committee on the Judiciary of the Senate of any such proposed limits.’. 
(2) CONFORMING AMENDMENT- Chapter 11 of title 35, United States 
Code, is amended by adding at the end the following new item: 
‘123. Micro entity defined.’. 
(h) Electronic Filing Incentive- 
(1) IN GENERAL- Notwithstanding any other provision of this section, an 
additional fee of $400 shall be established for each application for an 
original patent, except for a design, plant, or provisional application, that 
is not filed by electronic means as prescribed by the Director. The fee 
established by this subsection shall be reduced by 50 percent for small 
entities that qualify for reduced fees under section 41(h)(1) of title 35, 
United States Code. All fees paid under this subsection shall be deposited 
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in the Treasury as an offsetting receipt that shall not be available for 
obligation or expenditure. 
(2) EFFECTIVE DATE- This subsection shall take effect upon the 
expiration of the 60-day period beginning on the date of the enactment of 
this Act. 
(i) Effective Date; Sunset- 
(1) EFFECTIVE DATE- Except as provided in subsection (h), this section 
and the amendments made by this section shall take effect on the date of 
the enactment of this Act. 
(2) SUNSET- The authority of the Director to set or adjust any fee under 
subsection (a) shall terminate upon the expiration of the 7-year period 
beginning on the date of the enactment of this Act. 
(3) PRIOR REGULATIONS NOT AFFECTED- The termination of 
authority under this subsection shall not affect any regulations issued 
under this section before the effective date of such termination or any 
rulemaking proceeding for the issuance of regulations under this section 
that is pending on such date. 
SEC. 11. FEES FOR PATENT SERVICES. 
(a) General Patent Services- Subsections (a) and (b) of section 41 of title 35, 
United States Code, are amended to read as follows: 
‘(a) General Fees- The Director shall charge the following fees: 
‘(1) FILING AND BASIC NATIONAL FEES- 
‘(A) On filing each application for an original patent, except for 
design, plant, or provisional applications, $330. 
‘(B) On filing each application for an original design patent, $220. 
‘(C) On filing each application for an original plant patent, $220. 
‘(D) On filing each provisional application for an original patent, 
$220. 
‘(E) On filing each application for the reissue of a patent, $330. 
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‘(F) The basic national fee for each international application filed 
under the treaty defined in section 351(a) entering the national 
stage under section 371, $330. 
‘(G) In addition, excluding any sequence listing or computer 
program listing filed in an electronic medium as prescribed by the 
Director, for any application the specification and drawings of 
which exceed 100 sheets of paper (or equivalent as prescribed by 
the Director if filed in an electronic medium), $270 for each 
additional 50 sheets of paper (or equivalent as prescribed by the 
Director if filed in an electronic medium) or fraction thereof. 
‘(2) EXCESS CLAIMS FEES- 
‘(A) IN GENERAL- In addition to the fee specified in paragraph 
(1)-- 
‘(i) on filing or on presentation at any other time, $220 for 
each claim in independent form in excess of 3; 
‘(ii) on filing or on presentation at any other time, $52 for 
each claim (whether dependent or independent) in excess of 
20; and 
‘(iii) for each application containing a multiple dependent 
claim, $390. 
‘(B) MULTIPLE DEPENDENT CLAIMS- For the purpose of 
computing fees under subparagraph (A), a multiple dependent 
claim referred to in section 112 or any claim depending therefrom 
shall be considered as separate dependent claims in accordance 
with the number of claims to which reference is made. 
‘(C) REFUNDS; ERRORS IN PAYMENT- The Director may by 
regulation provide for a refund of any part of the fee specified in 
subparagraph (A) for any claim that is canceled before an 
examination on the merits, as prescribed by the Director, has been 
made of the application under section 131. Errors in payment of 
the additional fees under this paragraph may be rectified in 
accordance with regulations prescribed by the Director. 
‘(3) EXAMINATION FEES- 
‘(A) IN GENERAL- 
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‘(i) For examination of each application for an original 
patent, except for design, plant, provisional, or international 
applications, $220. 
‘(ii) For examination of each application for an original 
design patent, $140. 
‘(iii) For examination of each application for an original 
plant patent, $170. 
‘(iv) For examination of the national stage of each 
international application, $220. 
‘(v) For examination of each application for the reissue of a 
patent, $650. 
‘(B) APPLICABILITY OF OTHER FEE PROVISIONS- The 
provisions of paragraphs (3) and (4) of section 111(a) relating to 
the payment of the fee for filing the application shall apply to the 
payment of the fee specified in subparagraph (A) with respect to an 
application filed under section 111(a). The provisions of section 
371(d) relating to the payment of the national fee shall apply to the 
payment of the fee specified in subparagraph (A) with respect to an 
international application. 
‘(4) ISSUE FEES- 
‘(A) For issuing each original patent, except for design or plant 
patents, $1,510. 
‘(B) For issuing each original design patent, $860. 
‘(C) For issuing each original plant patent, $1,190. 
‘(D) For issuing each reissue patent, $1,510. 
‘(5) DISCLAIMER FEE- On filing each disclaimer, $140. 
‘(6) APPEAL FEES- 
‘(A) On filing an appeal from the examiner to the Patent Trial and 
Appeal Board, $540. 
‘(B) In addition, on filing a brief in support of the appeal, $540, 
and on requesting an oral hearing in the appeal before the Patent 
Trial and Appeal Board, $1,080. 
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‘(7) REVIVAL FEES- On filing each petition for the revival of an 
unintentionally abandoned application for a patent, for the unintentionally 
delayed payment of the fee for issuing each patent, or for an 
unintentionally delayed response by the patent owner in any 
reexamination proceeding, $1,620, unless the petition is filed under 
section 133 or 151, in which case the fee shall be $540. 
‘(8) EXTENSION FEES- For petitions for 1-month extensions of time to 
take actions required by the Director in an application-- 
‘(A) on filing a first petition, $130; 
‘(B) on filing a second petition, $360; and 
‘(C) on filing a third or subsequent petition, $620. 
‘(b) Maintenance Fees- 
‘(1) IN GENERAL- The Director shall charge the following fees for 
maintaining in force all patents based on applications filed on or after 
December 12, 1980: 
‘(A) Three years and 6 months after grant, $980. 
‘(B) Seven years and 6 months after grant, $2,480. 
‘(C) Eleven years and 6 months after grant, $4,110. 
‘(2) GRACE PERIOD; SURCHARGE- Unless payment of the applicable 
maintenance fee under paragraph (1) is received in the Office on or before 
the date the fee is due or within a grace period of 6 months thereafter, the 
patent shall expire as of the end of such grace period. The Director may 
require the payment of a surcharge as a condition of accepting within such 
6-month grace period the payment of an applicable maintenance fee. 
‘(3) NO MAINTENANCE FEE FOR DESIGN OR PLANT PATENT- No 
fee may be established for maintaining a design or plant patent in force.’. 
(b) Delays in Payment- Subsection (c) of section 41 of title 35, United States 
Code, is amended-- 
(1) by striking ‘(c)(1) The Director’ and inserting: 
‘(c) Delays in Payment of Maintenance Fees- 
‘(1) ACCEPTANCE- The Director’; and 
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(2) by striking ‘(2) A patent’ and inserting: 
‘(2) EFFECT ON RIGHTS OF OTHERS- A patent’. 
(c) Patent Search Fees- Subsection (d) of section 41 of title 35, United States 
Code, is amended to read as follows: 
‘(d) Patent Search and Other Fees- 
‘(1) PATENT SEARCH FEES- 
‘(A) IN GENERAL- The Director shall charge the fees specified 
under subparagraph (B) for the search of each application for a 
patent, except for provisional applications. The Director shall 
adjust the fees charged under this paragraph to ensure that the fees 
recover an amount not to exceed the estimated average cost to the 
Office of searching applications for patent by Office personnel. 
‘(B) SPECIFIC FEES- The fees referred to in subparagraph (A) 
are-- 
‘(i) $540 for each application for an original patent, except 
for design, plant, provisional, or international applications; 
‘(ii) $100 for each application for an original design patent; 
‘(iii) $330 for each application for an original plant patent; 
‘(iv) $540 for the national stage of each international 
application; and 
‘(v) $540 for each application for the reissue of a patent. 
‘(C) APPLICABILITY OF OTHER PROVISIONS- The 
provisions of paragraphs (3) and (4) of section 111(a) relating to 
the payment of the fee for filing the application shall apply to the 
payment of the fee specified in this paragraph with respect to an 
application filed under section 111(a). The provisions of section 
371(d) relating to the payment of the national fee shall apply to the 
payment of the fee specified in this paragraph with respect to an 
international application. 
‘(D) REFUNDS- The Director may by regulation provide for a 
refund of any part of the fee specified in this paragraph for any 
applicant who files a written declaration of express abandonment 
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as prescribed by the Director before an examination has been made 
of the application under section 131. 
‘(2) OTHER FEES- 
‘(A) IN GENERAL- The Director shall establish fees for all other 
processing, services, or materials relating to patents not specified 
in this section to recover the estimated average cost to the Office of 
such processing, services, or materials, except that the Director 
shall charge the following fees for the following services: 
‘(i) For recording a document affecting title, $40 per 
property. 
‘(ii) For each photocopy, $.25 per page. 
‘(iii) For each black and white copy of a patent, $3. 
‘(B) COPIES FOR LIBRARIES- The yearly fee for providing a 
library specified in section 12 with uncertified printed copies of the 
specifications and drawings for all patents in that year shall be 
$50.’. 
(d) Fees for Small Entities- Subsection (h) of section 41 of title 35, United States 
Code, is amended to read as follows: 
‘(h) Fees for Small Entities- 
‘(1) REDUCTIONS IN FEES- Subject to paragraph (3), fees charged 
under subsections (a), (b), and (d)(1) shall be reduced by 50 percent with 
respect to their application to any small business concern as defined under 
section 3 of the Small Business Act, and to any independent inventor or 
nonprofit organization as defined in regulations issued by the Director. 
‘(2) SURCHARGES AND OTHER FEES- With respect to its application 
to any entity described in paragraph (1), any surcharge or fee charged 
under subsection (c) or (d) shall not be higher than the surcharge or fee 
required of any other entity under the same or substantially similar 
circumstances. 
‘(3) REDUCTION FOR ELECTRONIC FILING- The fee charged under 
subsection (a)(1)(A) shall be reduced by 75 percent with respect to its 
application to any entity to which paragraph (1) applies, if the application 
is filed by electronic means as prescribed by the Director.’. 
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(e) Technical Amendments- Section 41 of title 35, United States Code, is 
amended-- 
(1) in subsection (e), in the first sentence, by striking ‘The Director’ and 
inserting ‘Waiver of Fees; Copies Regarding Notice- The Director’; 
(2) in subsection (f), by striking ‘The fees’ and inserting ‘Adjustment of 
Fees- The fees’; 
(3) by repealing subsection (g); and 
(4) in subsection (i)-- 
(A) by striking ‘(i)(1) The Director’ and inserting the following: 
‘(i) Electronic Patent and Trademark Data- 
‘(1) MAINTENANCE OF COLLECTIONS- The Director’; 
(B) by striking ‘(2) The Director’ and inserting the following: 
‘(2) AVAILABILITY OF AUTOMATED SEARCH SYSTEMS- The 
Director’; 
(C) by striking ‘(3) The Director’ and inserting the following: 
‘(3) ACCESS FEES- The Director’; and 
(D) by striking ‘(4) The Director’ and inserting the following: 
‘(4) ANNUAL REPORT TO CONGRESS- The Director’. 
(f) Adjustment of Trademark Fees- Section 802(a) of division B of the 
Consolidated Appropriations Act, 2005 (Public Law 108-447) is amended-- 
(1) in the first sentence, by striking ‘During fiscal years 2005, 2006, and 
2007,’, and inserting ‘Until such time as the Director sets or adjusts the 
fees otherwise,’; and 
(2) in the second sentence, by striking ‘During fiscal years 2005, 2006, 
and 2007, the’ and inserting ‘The’. 
(g) Effective Date, Applicability, and Transition Provisions- Section 803(a) of 
division B of the Consolidated Appropriations Act, 2005 (Public Law 108-447) is 
amended by striking ‘and shall apply only with respect to the remaining portion of 
fiscal year 2005 and fiscal year 2006’. 
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(h) Prioritized Examination Fee- 
(1) IN GENERAL- 
(A) FEE- 
(i) PRIORITIZED EXAMINATION FEE- A fee of $4,800 
shall be established for filing a request, pursuant to section 
2(b)(2)(G) of title 35, United States Code, for prioritized 
examination of a nonprovisional application for an original 
utility or plant patent. 
(ii) ADDITIONAL FEES- In addition to the prioritized 
examination fee under clause (i), the fees due on an 
application for which prioritized examination is being 
sought are the filing, search, and examination fees 
(including any applicable excess claims and application 
size fees), processing fee, and publication fee for that 
application. 
(B) REGULATIONS; LIMITATIONS- 
(i) REGULATIONS- The Director may by regulation 
prescribe conditions for acceptance of a request under 
subparagraph (A) and a limit on the number of filings for 
prioritized examination that may be accepted. 
(ii) LIMITATION ON CLAIMS- Until regulations are 
prescribed under clause (i), no application for which 
prioritized examination is requested may contain or be 
amended to contain more than 4 independent claims or 
more than 30 total claims. 
(iii) LIMITATION ON TOTAL NUMBER OF 
REQUESTS- The Director may not accept in any fiscal 
year more than 10,000 requests for prioritization until 
regulations are prescribed under this subparagraph setting 
another limit. 
(2) REDUCTION IN FEES FOR SMALL ENTITIES- The Director shall 
reduce fees for providing prioritized examination of nonprovisional 
applications for original utility and plant patents by 50 percent for small 
entities that qualify for reduced fees under section 41(h)(1) of title 35, 
United States Code. 
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(3) DEPOSIT OF FEES- All fees paid under this subsection shall be 
credited to the United States Patent and Trademark Office Appropriation 
Account, shall remain available until expended, and may be used only for 
the purposes specified in section 42(c)(3)(A) of title 35, United States 
Code. 
(4) EFFECTIVE DATE AND TERMINATION- 
(A) EFFECTIVE DATE- This subsection shall take effect on the 
date that is 10 days after the date of the enactment of this Act. 
(B) TERMINATION- The fee imposed under paragraph (1)(A)(i), 
and the reduced fee under paragraph (2), shall terminate on the 
effective date of the setting or adjustment of the fee under 
paragraph (1)(A)(i) pursuant to the exercise of the authority under 
section 10 for the first time with respect to that fee. 
(i) Appropriation Account Transition Fees- 
(1) SURCHARGE- 
(A) IN GENERAL- There shall be a surcharge of 15 percent, 
rounded by standard arithmetic rules, on all fees charged or 
authorized by subsections (a), (b), and (d)(1) of section 41, and 
section 132(b), of title 35, United States Code. Any surcharge 
imposed under this subsection is, and shall be construed to be, 
separate from and in addition to any other surcharge imposed 
under this Act or any other provision of law. 
(B) DEPOSIT OF AMOUNTS- Amounts collected pursuant to the 
surcharge imposed under subparagraph (A) shall be credited to the 
United States Patent and Trademark Appropriation Account, shall 
remain available until expended, and may be used only for the 
purposes specified in section 42(c)(3)(A) of title 35, United States 
Code. 
(2) EFFECTIVE DATE AND TERMINATION OF SURCHARGE- The 
surcharge provided for in paragraph (1)-- 
(A) shall take effect on the date that is 10 days after the date of the 
enactment of this Act; and 
(B) shall terminate, with respect to a fee to which paragraph (1)(A) 
applies, on the effective date of the setting or adjustment of that fee 
pursuant to the exercise of the authority under section 10 for the 
first time with respect to that fee. 
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(j) Effective Date- Except as otherwise provided in this section, this section and 
the amendments made by this section shall take effect on the date of the 
enactment of this Act. 
SEC. 12. SUPPLEMENTAL EXAMINATION. 
(a) In General- Chapter 25 of title 35, United States Code, is amended by adding 
at the end the following: 
-‘Sec. 257. Supplemental examinations to consider, reconsider, or correct information 
‘(a) Request for Supplemental Examination- A patent owner may request 
supplemental examination of a patent in the Office to consider, reconsider, or 
correct information believed to be relevant to the patent, in accordance with such 
requirements as the Director may establish. Within 3 months after the date a 
request for supplemental examination meeting the requirements of this section is 
received, the Director shall conduct the supplemental examination and shall 
conclude such examination by issuing a certificate indicating whether the 
information presented in the request raises a substantial new question of 
patentability. 
‘(b) Reexamination Ordered- If the certificate issued under subsection (a) 
indicates that a substantial new question of patentability is raised by 1 or more 
items of information in the request, the Director shall order reexamination of the 
patent. The reexamination shall be conducted according to procedures established 
by chapter 30, except that the patent owner shall not have the right to file a 
statement pursuant to section 304. During the reexamination, the Director shall 
address each substantial new question of patentability identified during the 
supplemental examination, notwithstanding the limitations in chapter 30 relating 
to patents and printed publication or any other provision of such chapter. 
‘(c) Effect- 
‘(1) IN GENERAL- A patent shall not be held unenforceable on the basis 
of conduct relating to information that had not been considered, was 
inadequately considered, or was incorrect in a prior examination of the 
patent if the information was considered, reconsidered, or corrected during 
a supplemental examination of the patent. The making of a request under 
subsection (a), or the absence thereof, shall not be relevant to 
enforceability of the patent under section 282. 
‘(2) EXCEPTIONS- 
‘(A) PRIOR ALLEGATIONS- Paragraph (1) shall not apply to an 
allegation pled with particularity in a civil action, or set forth with 
particularity in a notice received by the patent owner under section 
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505(j)(2)(B)(iv)(II) of the Federal Food, Drug, and Cosmetic Act 
(21 U.S.C. 355(j)(2)(B)(iv)(II)), before the date of a supplemental 
examination request under subsection (a) to consider, reconsider, 
or correct information forming the basis for the allegation. 
‘(B) PATENT ENFORCEMENT ACTIONS- In an action brought 
under section 337(a) of the Tariff Act of 1930 (19 U.S.C. 1337(a)), 
or section 281 of this title, paragraph (1) shall not apply to any 
defense raised in the action that is based upon information that was 
considered, reconsidered, or corrected pursuant to a supplemental 
examination request under subsection (a), unless the supplemental 
examination, and any reexamination ordered pursuant to the 
request, are concluded before the date on which the action is 
brought. 
‘(d) Fees and Regulations- 
‘(1) FEES- The Director shall, by regulation, establish fees for the 
submission of a request for supplemental examination of a patent, and to 
consider each item of information submitted in the request. If 
reexamination is ordered under subsection (b), fees established and 
applicable to ex parte reexamination proceedings under chapter 30 shall be 
paid, in addition to fees applicable to supplemental examination. 
‘(2) REGULATIONS- The Director shall issue regulations governing the 
form, content, and other requirements of requests for supplemental 
examination, and establishing procedures for reviewing information 
submitted in such requests. 
‘(e) Fraud- If the Director becomes aware, during the course of a supplemental 
examination or reexamination proceeding ordered under this section, that a 
material fraud on the Office may have been committed in connection with the 
patent that is the subject of the supplemental examination, then in addition to any 
other actions the Director is authorized to take, including the cancellation of any 
claims found to be invalid under section 307 as a result of a reexamination 
ordered under this section, the Director shall also refer the matter to the Attorney 
General for such further action as the Attorney General may deem appropriate. 
Any such referral shall be treated as confidential, shall not be included in the file 
of the patent, and shall not be disclosed to the public unless the United States 
charges a person with a criminal offense in connection with such referral. 
‘(f) Rule of Construction- Nothing in this section shall be construed-- 
‘(1) to preclude the imposition of sanctions based upon criminal or 
antitrust laws (including section 1001(a) of title 18, the first section of the 
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Clayton Act, and section 5 of the Federal Trade Commission Act to the 
extent that section relates to unfair methods of competition); 
‘(2) to limit the authority of the Director to investigate issues of possible 
misconduct and impose sanctions for misconduct in connection with 
matters or proceedings before the Office; or 
‘(3) to limit the authority of the Director to issue regulations under chapter 
3 relating to sanctions for misconduct by representatives practicing before 
the Office.’. 
(b) Conforming Amendment- The table of sections for chapter 25 of title 35, 
United States Code, is amended by adding at the end the following new item: 
‘257. Supplemental examinations to consider, reconsider, or correct 
information.’. 
(c) Effective Date- The amendments made by this section shall take effect upon 
the expiration of the 1-year period beginning on the date of the enactment of this 
Act and shall apply to any patent issued before, on, or after that effective date. 
SEC. 13. FUNDING AGREEMENTS. 
(a) In General- Section 202(c)(7)(E)(i) of title 35, United States Code, is 
amended-- 
(1) by striking ‘75 percent’ and inserting ‘15 percent’; 
(2) by striking ‘25 percent’ and inserting ‘85 percent’; and 
(3) by striking ‘as described above in this clause (D);’ and inserting 
‘described above in this clause;’. 
(b) Effective Date- The amendments made by this section shall take effect on the 
date of the enactment of this Act and shall apply to any patent issued before, on, 
or after that date. 
SEC. 14. TAX STRATEGIES DEEMED WITHIN THE PRIOR ART. 
(a) In General- For purposes of evaluating an invention under section 102 or 103 
of title 35, United States Code, any strategy for reducing, avoiding, or deferring 
tax liability, whether known or unknown at the time of the invention or 
application for patent, shall be deemed insufficient to differentiate a claimed 
invention from the prior art. 
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(b) Definition- For purposes of this section, the term ‘tax liability’ refers to any 
liability for a tax under any Federal, State, or local law, or the law of any foreign 
jurisdiction, including any statute, rule, regulation, or ordinance that levies, 
imposes, or assesses such tax liability. 
(c) Exclusions- This section does not apply to that part of an invention that-- 
(1) is a method, apparatus, technology, computer program product, or 
system, that is used solely for preparing a tax or information return or 
other tax filing, including one that records, transmits, transfers, or 
organizes data related to such filing; or 
(2) is a method, apparatus, technology, computer program product, or 
system used solely for financial management, to the extent that it is 
severable from any tax strategy or does not limit the use of any tax 
strategy by any taxpayer or tax advisor. 
(d) Rule of Construction- Nothing in this section shall be construed to imply that 
other business methods are patentable or that other business method patents are 
valid. 
(e) Effective Date; Applicability- This section shall take effect on the date of the 
enactment of this Act and shall apply to any patent application that is pending on, 
or filed on or after, that date, and to any patent that is issued on or after that date. 
SEC. 15. BEST MODE REQUIREMENT. 
(a) In General- Section 282 of title 35, United States Code, is amended in the 
second undesignated paragraph by striking paragraph (3) and inserting the 
following: 
‘(3) Invalidity of the patent or any claim in suit for failure to comply with-
- 
‘(A) any requirement of section 112, except that the failure to 
disclose the best mode shall not be a basis on which any claim of a 
patent may be canceled or held invalid or otherwise unenforceable; 
or 
‘(B) any requirement of section 251.’. 
(b) Conforming Amendment- Sections 119(e)(1) and 120 of title 35, United States 
Code, are each amended by striking ‘the first paragraph of section 112 of this 




(c) Effective Date- The amendments made by this section shall take effect upon 
the date of the enactment of this Act and shall apply to proceedings commenced 
on or after that date. 
SEC. 16. MARKING. 
(a) Virtual Marking- 
(1) IN GENERAL- Section 287(a) of title 35, United States Code, is 
amended by striking ‘or when,’ and inserting ‘or by fixing thereon the 
word ‘patent’ or the abbreviation ‘pat.’ together with an address of a 
posting on the Internet, accessible to the public without charge for 
accessing the address, that associates the patented article with the number 
of the patent, or when,’. 
(2) EFFECTIVE DATE- The amendment made by this subsection shall 
apply to any case that is pending on, or commenced on or after, the date of 
the enactment of this Act. 
(3) REPORT- Not later than the date that is 3 years after the date of the 
enactment of this Act, the Director shall submit a report to Congress that 
provides-- 
(A) an analysis of the effectiveness of ‘virtual marking’, as 
provided in the amendment made by paragraph (1) of this 
subsection, as an alternative to the physical marking of articles; 
(B) an analysis of whether such virtual marking has limited or 
improved the ability of the general public to access information 
about patents; 
(C) an analysis of the legal issues, if any, that arise from such 
virtual marking; and 
(D) an analysis of the deficiencies, if any, of such virtual marking. 
(b) False Marking- 
(1) CIVIL PENALTY- Section 292(a) of title 35, United States, Code, is 
amended by adding at the end the following: ‘Only the United States may 
sue for the penalty authorized by this subsection.’. 
(2) CIVIL ACTION FOR DAMAGES- Subsection (b) of section 292 of 
title 35, United States Code, is amended to read as follows: 
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‘(b) A person who has suffered a competitive injury as a result of a violation of 
this section may file a civil action in a district court of the United States for 
recovery of damages adequate to compensate for the injury.’. 
(3) EXPIRED PATENTS- Section 292 of title 35, United States Code, is 
amended by adding at the end the following: 
‘(c) The marking of a product, in a manner described in subsection (a), with 
matter relating to a patent that covered that product but has expired is not a 
violation of this section.’. 
(4) EFFECTIVE DATE- The amendments made by this subsection shall 
apply to all cases, without exception, that are pending on, or commenced 
on or after, the date of the enactment of this Act. 
SEC. 17. ADVICE OF COUNSEL. 
(a) In General- Chapter 29 of title 35, United States Code, is amended by adding 
at the end the following: 
-‘Sec. 298. Advice of counsel 
‘The failure of an infringer to obtain the advice of counsel with respect to any 
allegedly infringed patent, or the failure of the infringer to present such advice to 
the court or jury, may not be used to prove that the accused infringer willfully 
infringed the patent or that the infringer intended to induce infringement of the 
patent.’. 
[H.R. 6621, Sec. 1(a) reads: “Notwithstanding section 35 of the Leahy-Smith 
America Invents Act (35 U.S.C. 1 note), section 298 of title 35, United States 
Code, shall apply to any civil action commenced on or after the date of the 
enactment of this Act.” 
Analysis: H.R. 6621 would make clear that the prohibition on proving intent via 
failure to produce an opinion letter does not apply retroactively to suits filed 
before the section’s effective date.] 
(b) Conforming Amendment- The table of sections for chapter 29 of title 35, 
United States Code, is amended by adding at the end the following: 
‘298. Advice of counsel.’. 
SEC. 18. TRANSITIONAL PROGRAM FOR COVERED BUSINESS 
METHOD PATENTS. 
(a) Transitional Program- 
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(1) ESTABLISHMENT- Not later than the date that is 1 year after the date 
of the enactment of this Act, the Director shall issue regulations 
establishing and implementing a transitional post-grant review proceeding 
for review of the validity of covered business method patents. The 
transitional proceeding implemented pursuant to this subsection shall be 
regarded as, and shall employ the standards and procedures of, a post-
grant review under chapter 32 of title 35, United States Code, subject to 
the following: 
(A) Section 321(c) of title 35, United States Code, and subsections 
(b), (e)(2), and (f) of section 325 of such title shall not apply to a 
transitional proceeding. 
(B) A person may not file a petition for a transitional proceeding 
with respect to a covered business method patent unless the person 
or the person’s real party in interest or privy has been sued for 
infringement of the patent or has been charged with infringement 
under that patent. 
(C) A petitioner in a transitional proceeding who challenges the 
validity of 1 or more claims in a covered business method patent 
on a ground raised under section 102 or 103 of title 35, United 
States Code, as in effect on the day before the effective date set 
forth in section 3(n)(1), may support such ground only on the basis 
of-- 
(i) prior art that is described by section 102(a) of such title 
of such title (as in effect on the day before such effective 
date); or 
[Analysis: Typo correction.] 
(ii) prior art that-- 
(I) discloses the invention more than 1 year before 
the date of the application for patent in the United 
States; and 
(II) would be described by section 102(a) of such 
title (as in effect on the day before the effective date 
set forth in section 3(n)(1)) if the disclosure had 
been made by another before the invention thereof 
by the applicant for patent. 
(D) The petitioner in a transitional proceeding that results in a final 
written decision under section 328(a) of title 35, United States 
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Code, with respect to a claim in a covered business method patent, 
or the petitioner’s real party in interest, may not assert, either in a 
civil action arising in whole or in part under section 1338 of title 
28, United States Code, or in a proceeding before the International 
Trade Commission under section 337 of the Tariff Act of 1930 (19 
U.S.C. 1337), that the claim is invalid on any ground that the 
petitioner raised during that transitional proceeding. 
(E) The Director may institute a transitional proceeding only for a 
patent that is a covered business method patent. 
(2) EFFECTIVE DATE- The regulations issued under paragraph (1) shall 
take effect upon the expiration of the 1-year period beginning on the date 
of the enactment of this Act and shall apply to any covered business 
method patent issued before, on, or after that effective date, except that the 
regulations shall not apply to a patent described in section 6(f)(2)(A) of 
this Act during the period in which a petition for post-grant review of that 
patent would satisfy the requirements of section 321(c) of title 35, United 
States Code. 
(3) SUNSET- 
(A) IN GENERAL- This subsection, and the regulations issued 
under this subsection, are repealed effective upon the expiration of 
the 8-year period beginning on the date that the regulations issued 
under to paragraph (1) take effect. 
(B) APPLICABILITY- Notwithstanding subparagraph (A), this 
subsection and the regulations issued under this subsection shall 
continue to apply, after the date of the repeal under subparagraph 
(A), to any petition for a transitional proceeding that is filed before 
the date of such repeal. 
(b) Request for Stay- 
(1) IN GENERAL- If a party seeks a stay of a civil action alleging 
infringement of a patent under section 281 of title 35, United States Code, 
relating to a transitional proceeding for that patent, the court shall decide 
whether to enter a stay based on-- 
(A) whether a stay, or the denial thereof, will simplify the issues in 
question and streamline the trial; 




(C) whether a stay, or the denial thereof, would unduly prejudice 
the nonmoving party or present a clear tactical advantage for the 
moving party; and 
(D) whether a stay, or the denial thereof, will reduce the burden of 
litigation on the parties and on the court. 
(2) REVIEW- A party may take an immediate interlocutory appeal from a 
district court’s decision under paragraph (1). The United States Court of 
Appeals for the Federal Circuit shall review the district court’s decision to 
ensure consistent application of established precedent, and such review 
may be de novo. 
(c) ATM Exemption for Venue Purposes- In an action for infringement under 
section 281 of title 35, United States Code, of a covered business method patent, 
an automated teller machine shall not be deemed to be a regular and established 
place of business for purposes of section 1400(b) of title 28, United States Code. 
(d) Definition- 
(1) IN GENERAL- For purposes of this section, the term ‘covered 
business method patent’ means a patent that claims a method or 
corresponding apparatus for performing data processing or other 
operations used in the practice, administration, or management of a 
financial product or service, except that the term does not include patents 
for technological inventions. 
(2) REGULATIONS- To assist in implementing the transitional 
proceeding authorized by this subsectionsection, the Director shall issue 
regulations for determining whether a patent is for a technological 
invention. 
[Analysis: Typo correction.] 
(e) Rule of Construction- Nothing in this section shall be construed as amending 
or interpreting categories of patent-eligible subject matter set forth under section 
101 of title 35, United States Code. 
SEC. 19. JURISDICTION AND PROCEDURAL MATTERS. 
(a) State Court Jurisdiction- Section 1338(a) of title 28, United States Code, is 
amended by striking the second sentence and inserting the following: ‘No State 
court shall have jurisdiction over any claim for relief arising under any Act of 
Congress relating to patents, plant variety protection, or copyrights. For purposes 
of this subsection, the term ‘State’ includes any State of the United States, the 
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District of Columbia, the Commonwealth of Puerto Rico, the United States Virgin 
Islands, American Samoa, Guam, and the Northern Mariana Islands.’. 
(b) Court of Appeals for the Federal Circuit- Section 1295(a)(1) of title 28, United 
States Code, is amended to read as follows: 
‘(1) of an appeal from a final decision of a district court of the United 
States, the District Court of Guam, the District Court of the Virgin Islands, 
or the District Court of the Northern Mariana Islands, in any civil action 
arising under, or in any civil action in which a party has asserted a 
compulsory counterclaim arising under, any Act of Congress relating to 
patents or plant variety protection;’. 
(c) Removal- 
(1) IN GENERAL- Chapter 89 of title 28, United States Code, is amended 
by adding at the end the following new section: 
-‘Sec. 1454. Patent, plant variety protection, and copyright cases 
‘(a) In General- A civil action in which any party asserts a claim for relief arising 
under any Act of Congress relating to patents, plant variety protection, or 
copyrights may be removed to the district court of the United States for the 
district and division embracing the place where the action is pending. 
‘(b) Special Rules- The removal of an action under this section shall be made in 
accordance with section 1446, except that if the removal is based solely on this 
section-- 
‘(1) the action may be removed by any party; and 
‘(2) the time limitations contained in section 1446(b) may be extended at 
any time for cause shown. 
‘(c) Clarification of Jurisdiction in Certain Cases- The court to which a civil 
action is removed under this section is not precluded from hearing and 
determining any claim in the civil action because the State court from which the 
civil action is removed did not have jurisdiction over that claim. 
‘(d) Remand- If a civil action is removed solely under this section, the district 
court-- 
‘(1) shall remand all claims that are neither a basis for removal under 
subsection (a) nor within the original or supplemental jurisdiction of the 
district court under any Act of Congress; and 
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‘(2) may, under the circumstances specified in section 1367(c), remand 
any claims within the supplemental jurisdiction of the district court under 
section 1367.’. 
(2) CONFORMING AMENDMENT- The table of sections for chapter 89 
of title 28, United States Code, is amended by adding at the end the 
following new item: 
‘1454. Patent, plant variety protection, and copyright cases.’. 
(d) Procedural Matters in Patent Cases- 
(1) JOINDER OF PARTIES AND STAY OF ACTIONS- Chapter 29 of 
title 35, United States Code, as amended by this Act, is further amended 
by adding at the end the following new section: 
-‘Sec. 299. Joinder of parties 
‘(a) Joinder of Accused Infringers- With respect to any civil action arising under 
any Act of Congress relating to patents, other than an action or trial in which an 
act of infringement under section 271(e)(2) has been pled, parties that are accused 
infringers may be joined in one action as defendants or counterclaim defendants, 
or have their actions consolidated for trial, or counterclaim defendants only if— 
[Analysis: Typo correction.] 
‘(1) any right to relief is asserted against the parties jointly, severally, or in 
the alternative with respect to or arising out of the same transaction, 
occurrence, or series of transactions or occurrences relating to the making, 
using, importing into the United States, offering for sale, or selling of the 
same accused product or process; and 
‘(2) questions of fact common to all defendants or counterclaim 
defendants will arise in the action. 
‘(b) Allegations Insufficient for Joinder- For purposes of this subsection, accused 
infringers may not be joined in one action as defendants or counterclaim 
defendants, or have their actions consolidated for trial, based solely on allegations 
that they each have infringed the patent or patents in suit. 
‘(c) Waiver- A party that is an accused infringer may waive the limitations set 
forth in this section with respect to that party.’. 
(2) CONFORMING AMENDMENT- The table of sections for chapter 29 
of title 35, United States Code, as amended by this Act, is further amended 
by adding at the end the following new item: 
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‘299. Joinder of parties.’. 
(e) Effective Date- The amendments made by this section shall apply to any civil 
action commenced on or after the date of the enactment of this Act. 
SEC. 20. TECHNICAL AMENDMENTS. 
(a) Joint Inventions- Section 116 of title 35, United States Code, is amended-- 
(1) in the first undesignated paragraph, by striking ‘When’ and 
inserting ‘(a) Joint Inventions- When’; 
(2) in the second undesignated paragraph, by striking ‘If a joint 
inventor’ and inserting ‘(b) Omitted Inventor- If a joint inventor’; 
and 
(3) in the third undesignated paragraph-- 
(A) by striking ‘Whenever’ and inserting ‘(c) Correction of 
Errors in Application- Whenever’; and 
(B) by striking ‘and such error arose without any deceptive 
intention on his part,’. 
(b) Filing of Application in Foreign Country- Section 184 of title 35, United 
States Code, is amended-- 
(1) in the first undesignated paragraph-- 
(A) by striking ‘Except when’ and inserting ‘(a) Filing in Foreign 
Country- Except when’; and 
(B) by striking ‘and without deceptive intent’; 
(2) in the second undesignated paragraph, by striking ‘The term’ and 
inserting ‘(b) Application- The term’; and 
(3) in the third undesignated paragraph, by striking ‘The scope’ and 
inserting ‘(c) Subsequent Modifications, Amendments, and Supplements- 
The scope’. 
(c) Filing Without a License- Section 185 of title 35, United States Code, is 
amended by striking ‘and without deceptive intent’. 




(1) in the first undesignated paragraph-- 
(A) by striking ‘Whenever’ and inserting ‘(a) In General- 
Whenever’; and 
(B) by striking ‘without any deceptive intention’; 
(2) in the second undesignated paragraph, by striking ‘The Director’ and 
inserting ‘(b) Multiple Reissued Patents- The Director’; 
(3) in the third undesignated paragraph, by striking ‘The provisions’ and 
inserting ‘(c) Applicability of This Title- The provisions’; and 
(4) in the last undesignated paragraph, by striking ‘No reissued patent’ and 
inserting ‘(d) Reissue Patent Enlarging Scope of Claims- No reissued 
patent’. 
(e) Effect of Reissue- Section 253 of title 35, United States Code, is amended-- 
(1) in the first undesignated paragraph, by striking ‘Whenever, without 
any deceptive intention,’ and inserting ‘(a) In General- Whenever’; and 
(2) in the second undesignated paragraph, by striking ‘In like manner’ and 
inserting ‘(b) Additional Disclaimer or Dedication- In the manner set forth 
in subsection (a),’. 
(f) Correction of Named Inventor- Section 256 of title 35, United States Code, is 
amended-- 
(1) in the first undesignated paragraph-- 
(A) by striking ‘Whenever’ and inserting ‘(a) Correction- 
Whenever’; and 
(B) by striking ‘and such error arose without any deceptive 
intention on his part’; and 
(2) in the second undesignated paragraph, by striking ‘The error’ and 
inserting ‘(b) Patent Valid if Error Corrected- The error’. 
(g) Presumption of Validity- Section 282 of title 35, United States Code, is 
amended-- 
(1) in the first undesignated paragraph-- 
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(A) by striking ‘A patent’ and inserting ‘(a) In General- A patent’; 
and 
(B) by striking the third sentence; 
(2) in the second undesignated paragraph-- 
(A) by striking ‘The following’ and inserting ‘(b) Defenses- The 
following’; 
(B) in paragraph (1), by striking ‘uneforceability,’ and inserting 
‘unenforceability.’; and 
(C) in paragraph (2), by striking ‘patentability,’ and inserting 
‘patentability.’ ; and 
(3) in the third undesignated paragraph-- 
(A) by striking ‘In actions involving the validity or infringement of 
a patent’ and inserting ‘(c) Notice of Actions; Actions During 
Extension of Patent Term- In an action involving the validity or 
infringement of a patent’; and 
(B) by striking ‘Claims Court’ and inserting ‘Court of Federal 
Claims’. 
(h) Action for Infringement- Section 288 of title 35, United States Code, is 
amended by striking ‘, without deceptive intention,’. 
(i) Reviser’s Notes- 
(1) Section 3(e)(2) of title 35, United States Code, is amended by striking 
‘this Act,’ and inserting ‘that Act,’. 
(2) Section 202 of title 35, United States Code, is amended-- 
(A) in subsection (b)(3), by striking ‘the section 203(b)’ and 
inserting ‘section 203(b)’; and 
(B) in subsection (c)(7)(D), by striking ‘except where it proves’ 
and all that follows through ‘small business firms; and’ and 
inserting: ‘except where it is determined to be infeasible following 
a reasonable inquiry, a preference in the licensing of subject 
inventions shall be given to small business firms; and’. 
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(3) Section 209(d)(1) of title 35, United States Code, is amended by 
striking ‘nontransferrable’ and inserting ‘nontransferable’. 
(4) Section 287(c)(2)(G) of title 35, United States Code, is amended by 
striking ‘any state’ and inserting ‘any State’. 
(5) Section 371(b) of title 35, United States Code, is amended by striking 
‘of the treaty’ and inserting ‘of the treaty.’. 
(j) Unnecessary References- 
(1) IN GENERAL- Title 35, United States Code, is amended by striking 
‘of this title’ each place that term appears. 
(2) EXCEPTION- The amendment made by paragraph (1) shall not apply 
to the use of such term in the following sections of title 35, United States 
Code: 
(A) Section 1(c). 
(B) Section 101. 
(C) Subsections (a) and (b) of section 105. 
(D) The first instance of the use of such term in section 111(b)(8). 
(E) Section 161. 
(F) Section 164. 
(G) Section 171. 
(H) Section 251(c), as so designated by this section. 
(I) Section 261. 
(J) Subsections (g) and (h) of section 271. 
(K) Section 287(b)(1). 
(L) Section 289. 
(M) The first instance of the use of such term in section 375(a). 
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(k) Additional Technical Amendments- Sections 155 and 155A of title 35, United 
States Code, and the items relating to those sections in the table of sections for 
chapter 14 of such title, are repealed. 
(l) Effective Date- The amendments made by this section shall take effect upon 
the expiration of the 1-year period beginning on the date of the enactment of this 
Act and shall apply to proceedings commenced on or after that effective date. 
SEC. 21. TRAVEL EXPENSES AND PAYMENT OF 
ADMINISTRATIVE JUDGES. 
(a) Authority To Cover Certain Travel Related Expenses- Section 2(b)(11) of title 
35, United States Code, is amended by inserting ‘, and the Office is authorized to 
expend funds to cover the subsistence expenses and travel-related expenses, 
including per diem, lodging costs, and transportation costs, of persons attending 
such programs who are not Federal employees’ after ‘world’. 
(b) Payment of Administrative Judges- Section 3(b) of title 35, United States 
Code, is amended by adding at the end the following: 
‘(6) ADMINISTRATIVE PATENT JUDGES AND ADMINISTRATIVE 
TRADEMARK JUDGES- The Director may fix the rate of basic pay for 
the administrative patent judges appointed pursuant to section 6 and the 
administrative trademark judges appointed pursuant to section 17 of the 
Trademark Act of 1946 (15 U.S.C. 1067) at not greater than the rate of 
basic pay payable for level III of the Executive Schedule under section 
5314 of title 5. The payment of a rate of basic pay under this paragraph 
shall not be subject to the pay limitation under section 5306(e) or 5373 of 
title 5.’. 
[H.R. 6621, Sec. 1(g) reads: “Notwithstanding section 35 of the Leahy-Smith 
America Invents Act (35 U.S.C. 1 note), the amendments made by section 21 
of the Leahy-Smith America Invents Act (Public Law 112–29; 125 Stat. 335) 
shall be effective as of September 16, 2011.” 
Analysis: H.R. 6621 would make these changes to ALJs’ travel reimbursements 
effective immediately.] 
SEC. 22. PATENT AND TRADEMARK OFFICE FUNDING. 
(a) In General- Section 42(c) of title 35, United States Code, is amended-- 
(1) by striking ‘(c)’ and inserting ‘(c)(1)’; 
(2) in the first sentence, by striking ‘shall be available’ and inserting 
‘shall, subject to paragraph (3), be available’; 
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(3) by striking the second sentence; and 
(4) by adding at the end the following: 
‘(2) There is established in the Treasury a Patent and Trademark Fee Reserve 
Fund. If fee collections by the Patent and Trademark Office for a fiscal year 
exceed the amount appropriated to the Office for that fiscal year, fees collected in 
excess of the appropriated amount shall be deposited in the Patent and Trademark 
Fee Reserve Fund. To the extent and in the amounts provided in appropriations 
Acts, amounts in the Fund shall be made available until expended only for 
obligation and expenditure by the Office in accordance with paragraph (3). 
‘(3)(A) Any fees that are collected under sections 41, 42, and 376this title, and 
any surcharges on such fees, may only be used for expenses of the Office relating 
to the processing of patent applications and for other activities, services, and 
materials relating to patents and to cover a proportionate share of the 
administrative costs of the Office relating to patents. 
‘(B) Any fees that are collected under section 31 of the Trademark Act of 1946, 
and any surcharges on such fees, may only be used for expenses of the Office 
relating to the processing of trademark registrations and for other activities, 
services, and materials relating to trademarks and to cover a proportionate share 
of the administrative costs of the Office relating to trademarks.’. 
[Analysis: H.R. 6621 removes the requirement that PTO fees be segregated into 
patent- and trademark-specific funds.  Patent fees could be used to subsidize 
trademark costs and vice versa.] 
(b) Effective Date- The amendments made by this section shall take effect on 
October 1, 2011. 
SEC. 23. SATELLITE OFFICES. 
(a) Establishment- Subject to available resources, the Director shall, by not later 
than the date that is 3 years after the date of the enactment of this Act, establish 3 
or more satellite offices in the United States to carry out the responsibilities of the 
Office. 
(b) Purposes- The purposes of the satellite offices established under subsection (a) 
are to-- 
(1) increase outreach activities to better connect patent filers and 
innovators with the Office; 
(2) enhance patent examiner retention; 
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(3) improve recruitment of patent examiners; 
(4) decrease the number of patent applications waiting for examination; 
and 
(5) improve the quality of patent examination. 
(c) Required Considerations- 
(1) IN GENERAL- In selecting the location of each satellite office to be 
established under subsection (a), the Director-- 
(A) shall ensure geographic diversity among the offices, including 
by ensuring that such offices are established in different States and 
regions throughout the Nation; 
(B) may rely upon any previous evaluations by the Office of 
potential locales for satellite offices, including any evaluations 
prepared as part of the Office’s Nationwide Workforce Program 
that resulted in the 2010 selection of Detroit, Michigan, as the first 
satellite office of the Office; 
(C) shall evaluate and consider the extent to which the purposes of 
satellite offices listed under subsection (b) will be achieved; 
(D) shall consider the availability of scientific and technically 
knowledgeable personnel in the region from which to draw new 
patent examiners at minimal recruitment cost; and 
(E) shall consider the economic impact to the region. 
(2) OPEN SELECTION PROCESS- Nothing in paragraph (1) shall 
constrain the Office to only consider its evaluations in selecting the 
Detroit, Michigan, satellite office. 
(d) Report to Congress- Not later than the end of the third fiscal year that begins 
after the date of the enactment of this Act, the Director shall submit a report to 
Congress on-- 
(1) the rationale of the Director in selecting the location of any satellite 
office required under subsection (a), including an explanation of how the 
selected location will achieve the purposes of satellite offices listed under 
subsection (b) and how the required considerations listed under subsection 
(c) were met; 
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(2) the progress of the Director in establishing all such satellite offices; 
and 
(3) whether the operation of existing satellite offices is achieving the 
purposes under subsection (b). 
SEC. 24. DESIGNATION OF DETROIT SATELLITE OFFICE. 
(a) Designation- The satellite office of the United States Patent and Trademark 
Office to be located in Detroit, Michigan, shall be known and designated as the 
‘Elijah J. McCoy United States Patent and Trademark Office’. 
(b) References- Any reference in a law, map, regulation, document, paper, or 
other record of the United States to the satellite office of the United States Patent 
and Trademark Office to be located in Detroit, Michigan, referred to in subsection 
(a) shall be deemed to be a reference to the ‘Elijah J. McCoy United States Patent 
and Trademark Office’. 
SEC. 25. PRIORITY EXAMINATION FOR IMPORTANT 
TECHNOLOGIES. 
Section 2(b)(2) of title 35, United States Code, is amended-- 
(1) in subparagraph (E), by striking ‘and’ after the semicolon; 
(2) in subparagraph (F), by inserting ‘and’ after the semicolon; and 
(3) by adding at the end the following: 
‘(G) may, subject to any conditions prescribed by the Director and 
at the request of the patent applicant, provide for prioritization of 
examination of applications for products, processes, or 
technologies that are important to the national economy or national 
competitiveness without recovering the aggregate extra cost of 
providing such prioritization, notwithstanding section 41 or any 
other provision of law;’. 
SEC. 26. STUDY ON IMPLEMENTATION. 
(a) PTO Study- The Director shall conduct a study on the manner in which this 
Act and the amendments made by this Act are being implemented by the Office, 
and on such other aspects of the patent policies and practices of the Federal 
Government with respect to patent rights, innovation in the United States, 
competitiveness of United States markets, access by small businesses to capital 
for investment, and such other issues, as the Director considers appropriate. 
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(b) Report to Congress- The Director shall, not later than the date that is 4 years 
after the date of the enactment of this Act, submit to the Committees on the 
Judiciary of the House of Representatives and the Senate a report on the results of 
the study conducted under subsection (a), including recommendations for any 
changes to laws and regulations that the Director considers appropriate. 
SEC. 27. STUDY ON GENETIC TESTING. 
(a) In General- The Director shall conduct a study on effective ways to provide 
independent, confirming genetic diagnostic test activity where gene patents and 
exclusive licensing for primary genetic diagnostic tests exist. 
(b) Items Included in Study- The study shall include an examination of at least the 
following: 
(1) The impact that the current lack of independent second opinion testing 
has had on the ability to provide the highest level of medical care to 
patients and recipients of genetic diagnostic testing, and on inhibiting 
innovation to existing testing and diagnoses. 
(2) The effect that providing independent second opinion genetic 
diagnostic testing would have on the existing patent and license holders of 
an exclusive genetic test. 
(3) The impact that current exclusive licensing and patents on genetic 
testing activity has on the practice of medicine, including but not limited 
to: the interpretation of testing results and performance of testing 
procedures. 
(4) The role that cost and insurance coverage have on access to and 
provision of genetic diagnostic tests. 
(c) Confirming Genetic Diagnostic Test Activity Defined- For purposes of this 
section, the term ‘confirming genetic diagnostic test activity’ means the 
performance of a genetic diagnostic test, by a genetic diagnostic test provider, on 
an individual solely for the purpose of providing the individual with an 
independent confirmation of results obtained from another test provider’s prior 
performance of the test on the individual. 
(d) Report- Not later than 9 months after the date of enactment of this Act, the 
Director shall report to the Committee on the Judiciary of the Senate and the 
Committee on the Judiciary of the House of Representatives on the findings of the 
study and provide recommendations for establishing the availability of such 
independent confirming genetic diagnostic test activity. 
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SEC. 28. PATENT OMBUDSMAN PROGRAM FOR SMALL 
BUSINESS CONCERNS. 
Using available resources, the Director shall establish and maintain in the Office a 
Patent Ombudsman Program. The duties of the Program’s staff shall include 
providing support and services relating to patent filings to small business 
concerns and independent inventors. 
SEC. 29. ESTABLISHMENT OF METHODS FOR STUDYING THE 
DIVERSITY OF APPLICANTS. 
The Director shall, not later than the end of the 6-month period beginning on the 
date of the enactment of this Act, establish methods for studying the diversity of 
patent applicants, including those applicants who are minorities, women, or 
veterans. The Director shall not use the results of such study to provide any 
preferential treatment to patent applicants. 
SEC. 30. SENSE OF CONGRESS. 
It is the sense of Congress that the patent system should promote industries to 
continue to develop new technologies that spur growth and create jobs across the 
country which includes protecting the rights of small businesses and inventors 
from predatory behavior that could result in the cutting off of innovation. 
SEC. 31. USPTO STUDY ON INTERNATIONAL PATENT 
PROTECTIONS FOR SMALL BUSINESSES. 
(a) Study Required- The Director, in consultation with the Secretary of Commerce 
and the Administrator of the Small Business Administration, shall, using the 
existing resources of the Office, carry out a study-- 
(1) to determine how the Office, in coordination with other Federal 
departments and agencies, can best help small businesses with 
international patent protection; and 
(2) whether, in order to help small businesses pay for the costs of filing, 
maintaining, and enforcing international patent applications, there should 
be established either-- 
(A) a revolving fund loan program to make loans to small 
businesses to defray the costs of such applications, maintenance, 
and enforcement and related technical assistance; or 
(B) a grant program to defray the costs of such applications, 
maintenance, and enforcement and related technical assistance. 
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(b) Report- Not later than 120 days after the date of the enactment of this Act, the 
Director shall issue a report to the Congress containing-- 
(1) all findings and determinations made in carrying out the study required 
under subsection (a); 
(2) a statement of whether the determination was made that-- 
(A) a revolving fund loan program described under subsection 
(a)(2)(A) should be established; 
(B) a grant program described under subsection (a)(2)(B) should 
be established; or 
(C) neither such program should be established; and 
(3) any legislative recommendations the Director may have developed in 
carrying out such study. 
SEC. 32. PRO BONO PROGRAM. 
(a) In General- The Director shall work with and support intellectual property law 
associations across the country in the establishment of pro bono programs 
designed to assist financially under-resourced independent inventors and small 
businesses. 
(b) Effective Date- This section shall take effect on the date of the enactment of 
this Act. 
SEC. 33. LIMITATION ON ISSUANCE OF PATENTS. 
(a) Limitation- Notwithstanding any other provision of law, no patent may issue 
on a claim directed to or encompassing a human organism. 
(b) Effective Date- 
(1) IN GENERAL- Subsection (a) shall apply to any application for patent 
that is pending on, or filed on or after, the date of the enactment of this 
Act. 
(2) PRIOR APPLICATIONS- Subsection (a) shall not affect the validity 
of any patent issued on an application to which paragraph (1) does not 
apply. 
SEC. 34. STUDY OF PATENT LITIGATION. 
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(a) GAO Study- The Comptroller General of the United States shall conduct a 
study of the consequences of litigation by non-practicing entities, or by patent 
assertion entities, related to patent claims made under title 35, United States Code, 
and regulations authorized by that title. 
(b) Contents of Study- The study conducted under this section shall include the 
following: 
(1) The annual volume of litigation described in subsection (a) over the 
20-year period ending on the date of the enactment of this Act. 
(2) The volume of cases comprising such litigation that are found to be 
without merit after judicial review. 
(3) The impacts of such litigation on the time required to resolve patent 
claims. 
(4) The estimated costs, including the estimated cost of defense, associated 
with such litigation for patent holders, patent licensors, patent licensees, 
and inventors, and for users of alternate or competing innovations. 
(5) The economic impact of such litigation on the economy of the United 
States, including the impact on inventors, job creation, employers, 
employees, and consumers. 
(6) The benefit to commerce, if any, supplied by non-practicing entities or 
patent assertion entities that prosecute such litigation. 
(c) Report to Congress- The Comptroller General shall, not later than the date that 
is 1 year after the date of the enactment of this Act, submit to the Committee on 
the Judiciary of the House of Representatives and the Committee on the Judiciary 
of the Senate a report on the results of the study required under this section, 
including recommendations for any changes to laws and regulations that will 
minimize any negative impact of patent litigation that was the subject of such 
study. 
SEC. 35. EFFECTIVE DATE. 
Except as otherwise provided in this Act, the provisions of this Act shall take 
effect upon the expiration of the 1-year period beginning on the date of the 
enactment of this Act and shall apply to any patent issued on or after that effective 
date. 
SEC. 36. BUDGETARY EFFECTS. 
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The budgetary effects of this Act, for the purpose of complying with the Statutory 
Pay-As-You-Go Act of 2010, shall be determined by reference to the latest 
statement titled ‘Budgetary Effects of PAYGO Legislation’ for this Act, 
submitted for printing in the Congressional Record by the Chairman of the House 
Budget Committee, provided that such statement has been submitted prior to the 
vote on passage. 
SEC. 37. CALCULATION OF 60-DAY PERIOD FOR APPLICATION 
OF PATENT TERM EXTENSION. 
(a) In General- Section 156(d)(1) of title 35, United States Code, is amended by 
adding at the end the following flush sentence: 
‘For purposes of determining the date on which a product receives permission 
under the second sentence of this paragraph, if such permission is transmitted 
after 4:30 P.M., Eastern Time, on a business day, or is transmitted on a day that is 
not a business day, the product shall be deemed to receive such permission on the 
next business day. For purposes of the preceding sentence, the term ‘business day’ 
means any Monday, Tuesday, Wednesday, Thursday, or Friday, excluding any 
legal holiday under section 6103 of title 5.’. 
(b) Applicability- The amendment made by subsection (a) shall apply to any 
application for extension of a patent term under section 156 of title 35, United 
States Code, that is pending on, that is filed after, or as to which a decision 
regarding the application is subject to judicial review on, the date of the 
enactment of this Act. 
Speaker of the House of Representatives. 
Vice President of the United States and 
President of the Senate. 
 
